Unnamed: 0 stringlengths 3 8 | Date stringlengths 23 23 | Article_title stringlengths 1 250 | Stock_symbol stringlengths 1 5 | Url stringlengths 44 135 | Publisher stringclasses 1
value | Author stringclasses 1
value | Article stringlengths 1 343k | Lsa_summary stringlengths 3 53.9k | Luhn_summary stringlengths 1 53.9k | Textrank_summary stringlengths 1 53.9k | Lexrank_summary stringlengths 1 53.9k |
|---|---|---|---|---|---|---|---|---|---|---|---|
45700.0 | 2023-12-10 00:00:00 UTC | Nvidia CEO aims to set up a base in Vietnam | ACGLO | https://www.nasdaq.com/articles/nvidia-ceo-aims-to-set-up-a-base-in-vietnam | nan | nan | HANOI, Dec 10 (Reuters) - Nvidia NVDA.O wishes to establish a base in Vietnam to develop the country's semiconductor industry as it considers the Vietnamese market an important one, the Vietnamese government said, citing the U.S. chipmaker's chief executive.
In his first visit to the Southeast Asian country, Nvidia's C... | "The base will be for attracting talent from around the world to contribute to the development of Vietnam's semiconductor ecosystem and digitalisation," the Vietnamese government statement cited Huang after his meeting with Prime Minister Pham Minh Chinh. Nvidia, which has already invested $250 million in Vietnam, is s... | HANOI, Dec 10 (Reuters) - Nvidia NVDA.O wishes to establish a base in Vietnam to develop the country's semiconductor industry as it considers the Vietnamese market an important one, the Vietnamese government said, citing the U.S. chipmaker's chief executive. In his first visit to the Southeast Asian country, Nvidia's C... | HANOI, Dec 10 (Reuters) - Nvidia NVDA.O wishes to establish a base in Vietnam to develop the country's semiconductor industry as it considers the Vietnamese market an important one, the Vietnamese government said, citing the U.S. chipmaker's chief executive. Nvidia, which has already invested $250 million in Vietnam, i... | HANOI, Dec 10 (Reuters) - Nvidia NVDA.O wishes to establish a base in Vietnam to develop the country's semiconductor industry as it considers the Vietnamese market an important one, the Vietnamese government said, citing the U.S. chipmaker's chief executive. In his first visit to the Southeast Asian country, Nvidia's C... |
45701.0 | 2023-12-10 00:00:00 UTC | Green Giants- 7 Must-Buy Stocks for a Cleaner (More Profitable) Future | ACGLO | https://www.nasdaq.com/articles/green-giants-7-must-buy-stocks-for-a-cleaner-more-profitable-future | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Countries around the globe are trying to take the necessary steps to make our world a cleaner, and greener place. Leaders are talking about the impact of climate change. Several countries have laid out policies for the next decade. And while companies engag... | The one reason it is a safe bet is its regulated business, Florida Power & Light which keeps generating steady income over the years, and it also has a significant portfolio of renewable assets. More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move Before the Announcement Musk’s “Project Omega” May ... | Clean Energy Stocks: Li Auto (LI) Source: Robert Way / Shutterstock.com Electric vehicle makers are contributing towards building a cleaner and greener future. Clean Energy Stocks: Enterprise Products Partners (EPD) Source: Casimiro PT / Shutterstock.com One big reason to invest in Enterprise Products Partners (NYSE:EP... | Clean Energy Stocks: Enterprise Products Partners (EPD) Source: Casimiro PT / Shutterstock.com One big reason to invest in Enterprise Products Partners (NYSE:EPD) is its high dividend yield of 7.6%. I believe the company will be able to sustain the dividends in the coming years and you must buy the stock before it soar... | Clean Energy Stocks: Li Auto (LI) Source: Robert Way / Shutterstock.com Electric vehicle makers are contributing towards building a cleaner and greener future. This clean energy company has a long way to go and will keep rewarding you through steady dividends. The long-term demand for solar energy will remain high, and... |
45702.0 | 2023-12-10 00:00:00 UTC | Aercap Holdings N.V. Shares Climb 0.6% Past Previous 52-Week High - Market Mover | ACGLO | https://www.nasdaq.com/articles/aercap-holdings-n.v.-shares-climb-0.6-past-previous-52-week-high-market-mover | nan | nan | Aercap Holdings N.V. (AER) shares closed 0.6% higher than its previous 52 week high, giving the company a market cap of $15B. The stock is currently up 23.7% year-to-date, up 22.8% over the past 12 months, and up 48.2% over the past five years. This week, the Dow Jones Industrial Average rose 0.0%, and the S&P 500 rose... | Aercap Holdings N.V. (AER) shares closed 0.6% higher than its previous 52 week high, giving the company a market cap of $15B. Beta, a measure of the stock’s volatility relative to the overall market stands at 1.0. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a ... | This week, the Dow Jones Industrial Average rose 0.0%, and the S&P 500 rose 0.2%. Trading Activity Trading volume this week was 9.7% lower than the 20-day average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The co... | Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same ... | This week, the Dow Jones Industrial Average rose 0.0%, and the S&P 500 rose 0.2%. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and... |
45703.0 | 2023-12-10 00:00:00 UTC | One of This Year's Top-Performing Dow Stocks Could Continue Its Hot Streak in 2024 | ACGLO | https://www.nasdaq.com/articles/one-of-this-years-top-performing-dow-stocks-could-continue-its-hot-streak-in-2024 | nan | nan | The Dow Jones Industrial Average is underperforming both the Nasdaq Composite and the S&P 500 in 2023. But that's certainly not because of the tech stocks in the Dow.
At the time of this writing, the top-four best-performing Dow stocks so far this year are all tech stocks. Salesforce is up 89% year to date (YTD), Intel... | The short-term opportunity is integrating AI into existing business-to-consumer and business-to-business solutions -- basically making its products and services more useful and justifying higher subscription prices and increased adoption. This quarter, we added new capabilities with GitHub Copilot Chat, which are alrea... | Here's what Microsoft CEO Satya Nadella said about GitHub Copilot on the company's Q1 fiscal 2024earnings call With GitHub Copilot, we are increasing developer productivity by up to 55% while helping them stay in the flow and bringing the joy back to coding. In fiscal 2023, Microsoft generated $59.5 billion in free cas... | A relatable example of how AI is improving existing Microsoft solutions is Microsoft Copilots. The takeaway here is that there are ways for Microsoft to monetize AI across everything it already does, which unlocks growth from proven solutions without even accounting for the new markets and products that Microsoft eithe... | Copilots are generative AI that are integrated into existing applications. This is clearly the age of Copilots. An AI stock you can count on Microsoft is the perfect medium-risk/high-potential reward AI stock. |
45704.0 | 2023-12-10 00:00:00 UTC | What Mark Zuckerberg's Massive Meta Stock Dump Means for Investors | ACGLO | https://www.nasdaq.com/articles/what-mark-zuckerbergs-massive-meta-stock-dump-means-for-investors | nan | nan | Since the start of November 2023, Meta Platforms (META) CEO Mark Zuckerberg has sold over $228 million worth of company shares. The activity has drawn headline coverage in the financial media - but should Zuckerberg's recent unloading of META stock be a point of concern for long-term shareholders?
Generally, if company... | The activity has drawn headline coverage in the financial media - but should Zuckerberg's recent unloading of META stock be a point of concern for long-term shareholders? So, naturally, when a high-profile member of the management team reduces their position, investors might be worried - especially in light of META sto... | Since the start of November 2023, Meta Platforms (META) CEO Mark Zuckerberg has sold over $228 million worth of company shares. Analysts tracking META stock expect sales to rise by 14.5% to $133.56 billion in 2023 and by 13% to $151 billion in 2024. Out of the 38 analysts covering META, 36 recommend “strong buy,” one r... | Since the start of November 2023, Meta Platforms (META) CEO Mark Zuckerberg has sold over $228 million worth of company shares. Notably, this marks the first stock sale for Zuckerberg since 2021, after a brutal performance for tech stocks in 2022 - and most of the CEO's stake in META is held through preferred voting sh... | So, does Zuckerberg think the social media giant is overvalued at current prices? Analysts tracking META stock expect sales to rise by 14.5% to $133.56 billion in 2023 and by 13% to $151 billion in 2024. Priced at 18.8x forward earnings, META is still cheap, given its stellar growth estimates. |
45705.0 | 2023-12-10 00:00:00 UTC | Trillion-Dollar Trajectory: 3 Stocks on the Rise to Greatness | ACGLO | https://www.nasdaq.com/articles/trillion-dollar-trajectory%3A-3-stocks-on-the-rise-to-greatness | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
The uptick in job additions, as indicated by the anticipated November jobs report, holds significant benefits for the U.S. economy. A consistent rise in employment reflects economic resilience and stability, as more individuals secure employment for increas... | Moreover, a decline in the number of people receiving unemployment aid suggests a reduction in financial strain on both individuals and government resources, fostering a healthier economic landscape. Michael Que is a financial writer with extensive experience in the technology industry, with his work featured on Seekin... | Duolingo (DUOL) Source: dennizn / Shutterstock Duolingo (NASDAQ:DUOL) is an ed-tech SaaS company focused on the language learning market, garnering 83 million monthly users in Q3 2023 and 500 million registered. Delta Air Lines (DAL) Source: EQRoy / Shutterstock.com Delta Air Lines (NYSE:DAL) is an American airline tha... | Duolingo (DUOL) Source: dennizn / Shutterstock Duolingo (NASDAQ:DUOL) is an ed-tech SaaS company focused on the language learning market, garnering 83 million monthly users in Q3 2023 and 500 million registered. The flight market is valued at $130.90 billion and is projected to grow at a CAGR of 3.03% This growth is th... | Overall, the sustained growth in job numbers reflects positively on the nation’s economic vitality and the well-being of its citizens. Because of this positive report, these three trillion-dollar stocks are on a solid trajectory. Delta’s capitalization allows it to be a dominant player both domestically and internation... |
45706.0 | 2023-12-10 00:00:00 UTC | The 3 Best Cheap Stocks to Buy in December | ACGLO | https://www.nasdaq.com/articles/the-3-best-cheap-stocks-to-buy-in-december | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
The rising market in 2023 has not lifted all boats. Some stocks look extremely cheap right now. This offers investors an opportunity to buy shares of great companies at distressed prices and ride them higher in coming months and years. While some stocks are... | While some stocks are down for good reason, many have been dragged lower by cyclical economic factors, sector trends, and poor investor sentiment that are beyond the company’s control. Additionally, weighing on CVX stock right now and helping to pull it lower than other oil securities, is its proposed $53 billion acqui... | AbbVie (ABBV) Source: Valeriya Zankovych / Shutterstock.com Pharmaceutical giant AbbVie’s (NYSE:ABBV) stock looks cheap right now, having fallen 10% in 2023 and not far from its 52-week low. Dell Technologies (DELL) Source: Jonathan Weiss / Shutterstock.com Buy the pullback in Dell Technologies’ (NYSE:DELL) stock. The ... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips The rising market in 2023 has not lifted all boats. AbbVie (ABBV) Source: Valeriya Zankovych / Shutterstock.com Pharmaceutical giant AbbVie’s (NYSE:ABBV) stock looks cheap right now, having fallen 10% in 2023 and not far from its 52-week low. Dell Technolog... | Dell Technologies (DELL) Source: Jonathan Weiss / Shutterstock.com Buy the pullback in Dell Technologies’ (NYSE:DELL) stock. The company reported earnings per share (EPS) of $1.88, which was well above the Wall Street consensus of $1.46 a share. However, Dell’s revenue totaled $22.30 billion, down 10% from a year ago a... |
45707.0 | 2023-12-10 00:00:00 UTC | Crypto Is Heating Up Again -- Snag These 4 Cryptos Now | ACGLO | https://www.nasdaq.com/articles/crypto-is-heating-up-again-snag-these-4-cryptos-now | nan | nan | Heading into 2024, the crypto market is arguably one of the hottest areas of the investment world. Many top cryptos are up triple digits for the year, and analysts continue to pump out higher and higher price estimates for just how high these cryptos might go.
I've picked out four cryptos that I think should be on inve... | All rank among the top 10 cryptos in terms of market capitalization, all provide real utility and functionality (no meme coins! Official approval from the Securities and Exchange Commission (SEC) is supposed to come in the first quarter of the year, and when it does, an absolute tsunami of new institutional money could... | I've picked out four cryptos that I think should be on investors' year-end holiday shopping list: Bitcoin (CRYPTO: BTC), Solana (CRYPTO: SOL), XRP (CRYPTO: XRP), and Cardano (CRYPTO: ADA). Right now, Ethereum has a market cap of $270 billion while Solana has a market cap of $27 billion, so Solana might have 10x upside ... | I've picked out four cryptos that I think should be on investors' year-end holiday shopping list: Bitcoin (CRYPTO: BTC), Solana (CRYPTO: SOL), XRP (CRYPTO: XRP), and Cardano (CRYPTO: ADA). It makes sense to have Bitcoin represent at least half (and even more, if you're risk-averse) of any allocation to crypto, especial... | I've picked out four cryptos that I think should be on investors' year-end holiday shopping list: Bitcoin (CRYPTO: BTC), Solana (CRYPTO: SOL), XRP (CRYPTO: XRP), and Cardano (CRYPTO: ADA). Solana In terms of recent performance, Solana could be the single hottest cryptocurrency in the world right now. So, over time, one... |
45708.0 | 2023-12-10 00:00:00 UTC | 10X Titans: 3 Stocks Set to Dominate the Market by 2026 | ACGLO | https://www.nasdaq.com/articles/10x-titans%3A-3-stocks-set-to-dominate-the-market-by-2026 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
In the quest for portfolio supremacy, you should look to stocks of companies that are standing as vanguards, wielding the potential to reshape industries and dominate markets. Delving into the trajectories of three formidable stocks reveals unique strategic... | Despite facing challenges, such as a system outage impacting Square and Cash App, Block demonstrated resilience by swiftly addressing the issue, to the point that the down time is estimated to have affected gross profit by less than 1% during the quarter. Overall, Block’s customer-centric solutions, focusing on local s... | Iris Energy (IREN) Source: Sittipong Phokawattana / Shutterstock.com Iris Energy (NASDAQ:IREN) exhibits fundamental strengths that contribute to its growth potential, as evidenced by its strong operational foundation and scalability as of Q3 2023. For instance, in Q1 2024, career learning revenue surged 18%, and genera... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips In the quest for portfolio supremacy, you should look to stocks of companies that are standing as vanguards, wielding the potential to reshape industries and dominate markets. Thus, the positive outlook reinforces the company’s lead in sustained growth and ... | This article navigates their financial strengths, technological prowess, and market positioning. Iris Energy (IREN) Source: Sittipong Phokawattana / Shutterstock.com Iris Energy (NASDAQ:IREN) exhibits fundamental strengths that contribute to its growth potential, as evidenced by its strong operational foundation and sc... |
45709.0 | 2023-12-10 00:00:00 UTC | TSLA Stock Forecast: This Year Was Kind to Tesla. Why 2024 Won’t Be. | ACGLO | https://www.nasdaq.com/articles/tsla-stock-forecast%3A-this-year-was-kind-to-tesla.-why-2024-wont-be. | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Tesla (NASDAQ:TSLA)stock had a good year. Despite the antics of CEO Elon Musk, and the supposed “collapse” of the EV market, investors doubled their money.
Tesla has nearly doubled sales over the last two years, and it remains profitable. The company has sc... | By 2027, I expect better, safer batteries to deliver cars with the range of today’s Internal Combustion Engines (ICE), and at mid-market price points. He is the author of Technology’s Big Bang: Yesterday, Today and Tomorrow with Moore’s Law, available at the Amazon Kindle store. The Rich Use This Income Secret (NOT Div... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Tesla (NASDAQ:TSLA)stock had a good year. Despite the antics of CEO Elon Musk, and the supposed “collapse” of the EV market, investors doubled their money. Worries About TSLA Stock Tesla earned $2.3 billion, 66 cents per share, on revenue of $23.3 billion i... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Tesla (NASDAQ:TSLA)stock had a good year. But this, too, is already priced in Tesla stock, which is worth 8 times this year’s sales. I expect next year will be a rough one for Tesla and the entire EV industry. | Tesla is one of the very few EV companies that makes a profit. Tesla will still be around in 2027. But this, too, is already priced in Tesla stock, which is worth 8 times this year’s sales. |
45710.0 | 2023-12-10 00:00:00 UTC | This 1 Emerging Risk Could Be a Problem for These 3 Big Pharma Stocks | ACGLO | https://www.nasdaq.com/articles/this-1-emerging-risk-could-be-a-problem-for-these-3-big-pharma-stocks | nan | nan | On Nov. 28, the Food and Drug Administration (FDA) announced that it was opening an investigation into the possibility of previously unknown serious safety risks associated with the hottest and most technological group of cancer medicines produced to date. Now, drugmakers including Novartis (NYSE: NVS), Gilead Sciences... | On Nov. 28, the Food and Drug Administration (FDA) announced that it was opening an investigation into the possibility of previously unknown serious safety risks associated with the hottest and most technological group of cancer medicines produced to date. While there are safeguards to ensure that the editing process d... | Now, drugmakers including Novartis (NYSE: NVS), Gilead Sciences (NASDAQ: GILD), and Bristol Myers Squibb (NYSE: BMY) are on the hot seat, with their patients' well-being and billions of dollars in revenue on the line. Recent reports suggest that certain cancer patients treated with CAR T-cell therapies ultimately devel... | Recent reports suggest that certain cancer patients treated with CAR T-cell therapies ultimately developed lymphoma, or other closely related T-cell malignancies, as a result of treatment. Manufacturing CAR T-cell therapies involves editing the genes that define the core feature of all T-cells, the T-cell receptor (TCR... | Recent reports suggest that certain cancer patients treated with CAR T-cell therapies ultimately developed lymphoma, or other closely related T-cell malignancies, as a result of treatment. But in terms of financial exposure, it probably isn't under much pressure: Kymriah isn't among its top 20 medicines by revenue as o... |
45711.0 | 2023-12-10 00:00:00 UTC | Should You Buy Lucid Stock Instead of Tesla? | ACGLO | https://www.nasdaq.com/articles/should-you-buy-lucid-stock-instead-of-tesla | nan | nan | With shares down by a staggering 92% from an all-time high of $58 reached in early 2021, Lucid Motors' (NASDAQ: LCID) stock has been a poor bet for its early shareholders. And that's especially compared to the electric vehicle (EV) industry leader Tesla, which has risen 121% in 2023 alone. But with Tesla's valuation ge... | The problem has worsened in the near term because of macroeconomic challenges like high interest rates, which make it harder for consumers to finance their car purchases. To make matters worse, this can't be blamed solely on macroeconomic factors because Tesla managed to grow its sales by 5% in its corresponding period... | With shares down by a staggering 92% from an all-time high of $58 reached in early 2021, Lucid Motors' (NASDAQ: LCID) stock has been a poor bet for its early shareholders. And that's especially compared to the electric vehicle (EV) industry leader Tesla, which has risen 121% in 2023 alone. After all, the newsletter the... | Is Lucid a better buy than Tesla? 10 stocks we like better than Lucid Group When our analyst team has a stock tip, it can pay to listen. * They just revealed what they believe are the ten best stocks for investors to buy right now... and Lucid Group wasn't one of them! | For starters, the company aims to expand its product lineup with new offerings such as the Gravity, a new luxury SUV set to enter production in late 2024, and the recently released Sapphire, which is perhaps the fastest production sedan ever created. * They just revealed what they believe are the ten best stocks for in... |
45712.0 | 2023-12-10 00:00:00 UTC | Future in Fitness: 3 Stocks Innovating in Digital Health | ACGLO | https://www.nasdaq.com/articles/future-in-fitness%3A-3-stocks-innovating-in-digital-health | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Digital health and telemedicine are booming sectors offering attractive opportunities to investors looking to capitalize on the growing demand for remote healthcare. A couple of years ago, the Covid-19 pandemic accelerated the adoption of digital health sol... | According to a report by Grand View Research, the global digital health market size is expected to reach $809.2 billion by 2030, registering a compound annual growth rate of 18.6% from 2022 to 2023. Teladoc’s shares have struggled over the past 12 months after its misadventure in acquiring Livongo, a digital health pla... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Digital health and telemedicine are booming sectors offering attractive opportunities to investors looking to capitalize on the growing demand for remote healthcare. Amazon (AMZN) Source: Frederic Legrand - COMEO / Shutterstock.com The U.S. e-commerce giant... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Digital health and telemedicine are booming sectors offering attractive opportunities to investors looking to capitalize on the growing demand for remote healthcare. Doximity (DOCS) Source: Wirestock Creators / Shutterstock.com Doximity (NYSE:DOCS) is the f... | In recent years, the company has established itself as a leader in telehealth services with more than 80 million individuals in the United States “having access to one or more of [their] products and services,” according to their 2022 SEC 10K filing. Amazon (AMZN) Source: Frederic Legrand - COMEO / Shutterstock.com The... |
45713.0 | 2023-12-10 00:00:00 UTC | Riches Await: 3 Stocks with Multibagger Potential | ACGLO | https://www.nasdaq.com/articles/riches-await%3A-3-stocks-with-multibagger-potential | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Finding the next great investment is a challenging task. Usually, multibagger stocks are small-cap or mid-cap stocks that can grow into large caps through years of above-average revenue growth. However, these less known companies rarely hit the news headlin... | History has numerous examples of great companies with excellent revenue growth whose stocks stagnated for prolonged periods due to overvaluation. As the brand begins rolling out its retail store concepts, it will gain more visibility, showcase its products better and add another revenue channel. Charles Munyi has exten... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Finding the next great investment is a challenging task. The shoemaker has created a buzz by creating stylish, comfortable running shoes that consumers love. In the third quarter, net sales increased 58% year-over-year on a constant currency basis. | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Finding the next great investment is a challenging task. Usually, multibagger stocks are small-cap or mid-cap stocks that can grow into large caps through years of above-average revenue growth. Notably, the company has maintained quarterly revenue growth ab... | The following three companies are potential multibagger stocks. However, construction is a massive growing industry, and Procore has just begun penetrating the market. Notably, the company has maintained quarterly revenue growth above 30% since Q4 2021. |
45714.0 | 2023-12-10 00:00:00 UTC | The New Elite: 3 Stocks Poised to Join the Magnificent 7 | ACGLO | https://www.nasdaq.com/articles/the-new-elite%3A-3-stocks-poised-to-join-the-magnificent-7 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
The Magnificent 7 stocks have led market indices higher in recent years. These few stocks have created generational wealth for some of their long-term investors. Despite the high gains, many of these stocks still have growth opportunities and can continue r... | Zscaler helps to protect business owners from facing those scenarios and high legal bills related to cyberattacks. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. The Rich Use This Income Secret (NOT Dividends) Far More... | Supermicro (SMCI) Source: shutterstock.com/YAKOBCHUK V Supermicro (NASDAQ:SMCI) has tailwinds similar to Nvidia’s as the artificial intelligence industry heats up. Zscaler (ZS) Source: Sundry Photography / Shutterstock.com Zscaler (NASDAQ:ZS) is a riskier stock since the company relies on high revenue growth to justify... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips The Magnificent 7 stocks have led market indices higher in recent years. The company’s stock price has managed to outperform Nvidia over the past five years with a 1,559% gain. Zscaler (ZS) Source: Sundry Photography / Shutterstock.com Zscaler (NASDAQ:ZS) i... | Supermicro (SMCI) Source: shutterstock.com/YAKOBCHUK V Supermicro (NASDAQ:SMCI) has tailwinds similar to Nvidia’s as the artificial intelligence industry heats up. Zscaler reported 40% year-over-year revenue growth in the first quarter of fiscal 2024. The good times may keep on coming as the company recently became pro... |
45715.0 | 2023-12-10 00:00:00 UTC | Is Shopify a Buy Now? | ACGLO | https://www.nasdaq.com/articles/is-shopify-a-buy-now-1 | nan | nan | This year, the Nasdaq Composite Index has risen by 37% (as of Dec. 8), which is an outstanding gain, especially after the huge decline in 2022.
However, some businesses, like Shopify (NYSE: SHOP), have rewarded investors even more. Its shares have more than doubled in 2023 amid a resurgence in growth-tech stocks.
After... | Looking ahead, it's encouraging to know that online shopping still only commands less than 16% of overall retail spending in the U.S. As a leader in the e-commerce platform market, Shopify is poised to continue benefiting from this secular trend. And to rightsize operations, Shopify disposed of its logistics unit, whic... | The company reported revenue of $1.7 billion, which was up 25% year over year. Before you buy stock in Shopify, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Shopify wasn't one of them. See the 10 stocks *Stock Advisor ... | Profits matter Growth is a critical part of this company's story, but perhaps a key reason the stock has done so well is because of Shopify's improving profitability. Before you buy stock in Shopify, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for i... | The company reported revenue of $1.7 billion, which was up 25% year over year. Profits matter Growth is a critical part of this company's story, but perhaps a key reason the stock has done so well is because of Shopify's improving profitability. See the 10 stocks *Stock Advisor returns as of December 7, 2023 Neil Patel... |
45716.0 | 2023-12-10 00:00:00 UTC | A Bull Market Is Coming: 2 Magnificent Growth Stocks to Buy Hand Over Fist Before They Soar 491% and 138%, According to Certain Wall Street Analysts | ACGLO | https://www.nasdaq.com/articles/a-bull-market-is-coming%3A-2-magnificent-growth-stocks-to-buy-hand-over-fist-before-they-2 | nan | nan | The year 2023 is set to end on an impressive note for the U.S. stock market -- a remarkable turnaround from the disastrous performance in 2022. With inflation cooling down at a faster-than-expected pace, many analysts expect the Federal Reserve to stop the interest rate hikes. While there is no certain timeline for the... | Roku A recent Kagan U.S. Consumer Insights survey revealed that 35% of U.S. households discontinued their pay-TV subscriptions in the third quarter of 2023 (ending Sept. 30, 2023), an 8 percentage point increase on a year-over-year basis. The significant scale, combined with increasing user engagement, access to first-... | Against this backdrop, it makes sense for retail investors to pick small stakes in fundamentally strong stocks with significant upside potential ahead of a potential bull market. Wood's Ark Invest expects Roku's share price to reach $605 by 2026 (base case scenario), implying an upside potential of 491% from its share ... | Here are two stocks -- Roku (NASDAQ: ROKU) and SoundHound AI (NASDAQ: SOUN) -- that investors can consider buying hand over fist now before they soar 491% and 138%, according to select Wall Street analysts. Before you buy stock in Roku, consider this: The Motley Fool Stock Advisor analyst team just identified what they... | SoundHound AI now estimates its target addressable market to be $160 billion by 2026. In Q3 (ending Sept. 30, 2023), revenue jumped by 19% year over year to $13.3 million. Before you buy stock in Roku, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for... |
45717.0 | 2023-12-10 00:00:00 UTC | Amazon Is Closing Out a Stellar Year. Is It Too Late to Invest in AMZN Stock for 2024? | ACGLO | https://www.nasdaq.com/articles/amazon-is-closing-out-a-stellar-year.-is-it-too-late-to-invest-in-amzn-stock-for-2024 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
With less than a month left in 2023, Amazon (NASDAQ:AMZN) stock is up 71% year-to-date. It’s now 28% away from its June 2021 all-time high of $188.65. Everything seems to go Amazon’s way. Even its $1.4 billion tentative iRobot (NASDAQ:IRBT) acquisition — it... | Even its $1.4 billion tentative iRobot (NASDAQ:IRBT) acquisition — it’s been in limbo since the deal was first announced in August 2022 — looks to have passed inspection with EU antitrust regulators. A recent Motley Fool article pointed out that Amazon’s services segment (Prime, AWS, advertising) generates 56% of its o... | A recent Motley Fool article pointed out that Amazon’s services segment (Prime, AWS, advertising) generates 56% of its overall revenue compared to 44% for its e-commerce and brick-and-mortar retail sales. On an annualized basis, AWS sales in 2023 are projected to be $88.8 billion ($66.6 billion / 3 * 4), an 11% increas... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips With less than a month left in 2023, Amazon (NASDAQ:AMZN) stock is up 71% year-to-date. A recent Motley Fool article pointed out that Amazon’s services segment (Prime, AWS, advertising) generates 56% of its overall revenue compared to 44% for its e-commerce... | Everything seems to go Amazon’s way. As for AI, it announced Amazon Q on Nov. 28, a chatbot for businesses that will initially cost $20 per user per month. Is It Too Late to Invest in AMZN Stock for 2024? |
45718.0 | 2023-12-10 00:00:00 UTC | Stellantis Just Passed Ford and GM in the Electric Vehicle Race. Is It a Buy? | ACGLO | https://www.nasdaq.com/articles/stellantis-just-passed-ford-and-gm-in-the-electric-vehicle-race.-is-it-a-buy | nan | nan | Right now major automakers are battling to turn their electric vehicle (EV) lineups into a profitable segment. Ford Motor Company projects its EV unit will check in with a $4.5 billion loss for 2023 -- a hefty chunk of change lost. And while General Motors plans to produce profitable EVs in 2025, a year ahead of Ford, ... | Ford Motor Company projects its EV unit will check in with a $4.5 billion loss for 2023 -- a hefty chunk of change lost. This is big news for an automaker often lurking in the shadows of crosstown rivals Ford and GM, and an important part of its broader story of aiming for 75 battery-electric vehicles (BEVs) globally b... | And while General Motors plans to produce profitable EVs in 2025, a year ahead of Ford, Stellantis (NYSE: STLA) shocked everyone with an announcement about its EVs this week. Before you buy stock in Stellantis, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best s... | And while General Motors plans to produce profitable EVs in 2025, a year ahead of Ford, Stellantis (NYSE: STLA) shocked everyone with an announcement about its EVs this week. But wait, there's more Stellantis also struck a deal with Chinese EV maker Leapmotor that will enable the automaker to deliver additional profita... | And while General Motors plans to produce profitable EVs in 2025, a year ahead of Ford, Stellantis (NYSE: STLA) shocked everyone with an announcement about its EVs this week. With the announcement that Stellantis is now in the black with its EVs in Europe and the U.S., it's one more reason the automaker should at least... |
45719.0 | 2023-12-10 00:00:00 UTC | Validea's Top Health Care Stocks Based On Joel Greenblatt - 12/10/2023 | ACGLO | https://www.nasdaq.com/articles/valideas-top-health-care-stocks-based-on-joel-greenblatt-12-10-2023 | nan | nan | The following are the top rated Health Care stocks according to Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields.
COLLEGIUM PHARMACEUTICAL INC (COLL) is a small-cap growth stock in the Biotech... | Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women's health. Its products include Revlimid, Abecma, Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Sprycel, Yervoy, Abraxane, Empliciti, Reblozyl, In... | Detailed Analysis of INMODE LTD INMD Guru Analysis INMD Fundamental Analysis MCKESSON CORP (MCK) is a large-cap growth stock in the Major Drugs industry. Detailed Analysis of MCKESSON CORP MCK Guru Analysis MCK Fundamental Analysis BRISTOL-MYERS SQUIBB CO (BMY) is a large-cap value stock in the Biotechnology & Drugs in... | The Company commercializes its pain portfolio, consisting of Xtampza extended-release (ER), Nucynta Products, Belbuca, and Symproic in the United States. Its Prescription Technology Solutions segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to conn... | The Company commercializes its pain portfolio, consisting of Xtampza extended-release (ER), Nucynta Products, Belbuca, and Symproic in the United States. Detailed Analysis of BRISTOL-MYERS SQUIBB CO BMY Guru Analysis BMY Fundamental Analysis Joel Greenblatt Portfolio Top Joel Greenblatt Stocks About Joel Greenblatt: In... |
45720.0 | 2023-12-10 00:00:00 UTC | This Can't Possibly Be a Great Stock, Can It? But It's Up 166% for Patient Investors | ACGLO | https://www.nasdaq.com/articles/this-cant-possibly-be-a-great-stock-can-it-but-its-up-166-for-patient-investors | nan | nan | Five years ago, General Electric (NYSE: GE) was seen by many as a company whose very survival was at stake. However, those fears proved overly pessimistic, and its stock rose 166% over that period.
It's a superb performance, notably as it occurred under some tough conditions for the company, with some bad luck along th... | Culp's solution to the problem was a combination of significant portfolio restructuring, business sales, cash-raising spinoffs, and excellent execution in difficult trading conditions. Two examples of General Electric's execution To outline how Culp's focus on lean operations has worked, consider the turnaround at GE P... | With GE Healthcare now a stand-alone company, the next stage in the company's evolution will be the spinoff of GE Vernova in 2024 (a combination of GE Power and GE Renewable Energy), leaving the remaining company to be called GE Aerospace. General Electric's execution The business sales, spinoffs, and stock sales have ... | With GE Healthcare now a stand-alone company, the next stage in the company's evolution will be the spinoff of GE Vernova in 2024 (a combination of GE Power and GE Renewable Energy), leaving the remaining company to be called GE Aerospace. General Electric's execution The business sales, spinoffs, and stock sales have ... | With GE Healthcare now a stand-alone company, the next stage in the company's evolution will be the spinoff of GE Vernova in 2024 (a combination of GE Power and GE Renewable Energy), leaving the remaining company to be called GE Aerospace. Two examples of General Electric's execution To outline how Culp's focus on lean... |
45721.0 | 2023-12-10 00:00:00 UTC | Validea's Top Health Care Stocks Based On Martin Zweig - 12/10/2023 | ACGLO | https://www.nasdaq.com/articles/valideas-top-health-care-stocks-based-on-martin-zweig-12-10-2023 | nan | nan | The following are the top rated Health Care stocks according to Validea's Growth Investor model based on the published strategy of Martin Zweig. This strategy looks for growth stocks with persistent accelerating earnings and sales growth, reasonable valuations and low debt.
ALIGN TECHNOLOGY, INC. (ALGN) is a large-cap ... | The AI segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. He has owned what Forbes reported was the most expensive apartment in New York, a $70 million penthouse that sits ato... | Detailed Analysis of ALIGN TECHNOLOGY, INC. ALGN Guru Analysis ALGN Fundamental Analysis LEMAITRE VASCULAR INC (LMAT) is a small-cap growth stock in the Medical Equipment & Supplies industry. Detailed Analysis of FIGS INC FIGS Guru Analysis FIGS Fundamental Analysis GRIFOLS SA - ADR (GRFS) is a mid-cap growth stock in ... | Its Clear Aligner segment consists of Comprehensive Products, which includes Invisalign Comprehensive and Invisalign First; Non-Comprehensive Products, which includes Invisalign Moderate, Lite and Express packages and Invisalign Go, and Non-Case products, which include retention products, Invisalign training, adjusting... | The following are the top rated Health Care stocks according to Validea's Growth Investor model based on the published strategy of Martin Zweig. The Company offers apparel and products for healthcare professionals. Company Description: RadNet, Inc. is a provider of diagnostic imaging services in the United States. |
45722.0 | 2023-12-10 00:00:00 UTC | 3 Stocks at the Forefront of Medical Robotics | ACGLO | https://www.nasdaq.com/articles/3-stocks-at-the-forefront-of-medical-robotics | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Every now and then, speculation – within carefully defined limits – may be appropriate, which brings us to the case for medical robotics stocks to buy. Sure, you can gamble on just about anything these days and a non-zero probability exists for their upside... | Per its public profile, Globus focuses on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders. Read More: Penny Stocks — How to Profit Without Getting Scammed On the date of publication, Josh Enomoto did not have (either directly ... | According to Grand View Research, the global medical robotic systems market size reached a valuation of $21.1 billion last year. Broadly speaking, Allied Market Research states that the global musculoskeletal disorders drugs market size reached a valuation of $83.5 billion last year. According to Grand View Research, t... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Every now and then, speculation – within carefully defined limits – may be appropriate, which brings us to the case for medical robotics stocks to buy. Globus Medical (GMED) Source: THICHA SATAPITANON / Shutterstock Based in Pennsylvania, Globus Medical (NY... | Thus, GMED could be one of the medical robotics stocks to consider. But if you do believe, it could be one of the medical robotics stocks to consider. Penny Stocks On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of ... |
45723.0 | 2023-12-10 00:00:00 UTC | Validea's Top Health Care Stocks Based On John Neff - 12/10/2023 | ACGLO | https://www.nasdaq.com/articles/valideas-top-health-care-stocks-based-on-john-neff-12-10-2023 | nan | nan | The following are the top rated Health Care stocks according to Validea's Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth that trade at a discount relative to their earnings growth and dividend yield.
ZOETIS INC (ZTS) is a large-cap growt... | The following are the top rated Health Care stocks according to Validea's Low PE Investor model based on the published strategy of John Neff. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and pr... | Detailed Analysis of ZOETIS INC ZTS Guru Analysis ZTS Fundamental Analysis HUMANA INC (HUM) is a large-cap growth stock in the Healthcare Facilities industry. Detailed Analysis of HUMANA INC HUM Guru Analysis HUM Fundamental Analysis STRYKER CORP (SYK) is a large-cap growth stock in the Medical Equipment & Supplies ind... | Detailed Analysis of HUMANA INC HUM Guru Analysis HUM Fundamental Analysis STRYKER CORP (SYK) is a large-cap growth stock in the Medical Equipment & Supplies industry. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equi... | Company Description: Zoetis Inc. is an animal health company. Company Description: Stryker Corporation (Stryker) is a medical technology company. Validea offers both stock analysis and model portfolios based on gurus who have outperformed the market over the long-term, including Warren Buffett, Benjamin Graham, Peter L... |
45724.0 | 2023-12-10 00:00:00 UTC | Tesla Stock to Drop 40% in 2024, According to This Analyst | ACGLO | https://www.nasdaq.com/articles/tesla-stock-to-drop-40-in-2024-according-to-this-analyst | nan | nan | In this week's video, I cover need-to-know news items related to Tesla (NASDAQ: TSLA) during the week of Dec. 4. Today's video will focus on Tesla's sales numbers in China and Europe, the company's future expansion projects, why an analyst at Bernstein is calling Tesla the best short idea for 2024, and a look at Tesla ... | Where to invest $1,000 right now When our analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for two decades, Motley Fool Stock Advisor, has more than tripled the market. If you choose to subscribe through his link, he will earn some extra money that supports his channel. | In this week's video, I cover need-to-know news items related to Tesla (NASDAQ: TSLA) during the week of Dec. 4. After all, the newsletter they have run for two decades, Motley Fool Stock Advisor, has more than tripled the market. See the 10 stocks *Stock Advisor returns as of December 7, 2023 Neil Rozenbaum has positi... | Today's video will focus on Tesla's sales numbers in China and Europe, the company's future expansion projects, why an analyst at Bernstein is calling Tesla the best short idea for 2024, and a look at Tesla stock from a technical analysis standpoint. * They just revealed what they believe are the ten best stocks for in... | In this week's video, I cover need-to-know news items related to Tesla (NASDAQ: TSLA) during the week of Dec. 4. See the 10 stocks *Stock Advisor returns as of December 7, 2023 Neil Rozenbaum has positions in Tesla. His opinions remain his own and are unaffected by The Motley Fool. |
45725.0 | 2023-12-10 00:00:00 UTC | Should You Buy This Unstoppable Stock Before the End of 2023? | ACGLO | https://www.nasdaq.com/articles/should-you-buy-this-unstoppable-stock-before-the-end-of-2023 | nan | nan | I'm a big fan of Peter Lynch's classic book about investing, One Up on Wall Street, and of the philosophy he describes. Part of that is the really simple approach of finding companies you love and that offer products and services that your friends are using, and investing in them as they take off.
If you chose to inves... | Part of that is the really simple approach of finding companies you love and that offer products and services that your friends are using, and investing in them as they take off. The newest premium footwear craze On is best known for its Cloud running and walking shoes, which feature innovative soles and unique designs... | In On's case, this is a lucrative market that pays full price, driving margin expansion and profits. Management has espoused a four-pillar growth strategy: increasing brand awareness; expanding its footprint through a targeted, omnichannel program; innovation; and dedication to operational excellence. The Motley Fool h... | On sees a current market opportunity of $25 billion in its running-related merchandise, but it plans to expand its collection to compete for a slice of the $70 billion addressable market in premium lifestyle and sport, eventually growing to enter the full activewear market that it sees as being worth $355 billion. On H... | However, if you pay attention now, you could find the next Lululemon or Starbucks. Driving growth through targeted expansion One thing On is not is Nike. By contrast, On is still building its brand, its edge, and its customer base. |
45726.0 | 2023-12-10 00:00:00 UTC | Validea's Top Health Care Stocks Based On Joseph Piotroski - 12/10/2023 | ACGLO | https://www.nasdaq.com/articles/valideas-top-health-care-stocks-based-on-joseph-piotroski-12-10-2023 | nan | nan | The following are the top rated Health Care stocks according to Validea's Book/Market Investor model based on the published strategy of Joseph Piotroski. This value-quant strategy screens for high book-to-market stocks, and then separates out financially sound firms by looking at a host of improving financial criteria.... | Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, and Bake Sale, among others. But in 2000, shortly after he started teaching at the University of Chicago's Graduate School of Business, Piotroski published a groundbreaking paper in the Journal of Accounting Research entit... | Detailed Analysis of AVANOS MEDICAL INC AVNS Guru Analysis AVNS Fundamental Analysis TILRAY BRANDS INC (TLRY) is a small-cap growth stock in the Biotechnology & Drugs industry. Detailed Analysis of TILRAY BRANDS INC TLRY Guru Analysis TLRY Fundamental Analysis ADAPTHEALTH CORP (AHCO) is a small-cap growth stock in the ... | Detailed Analysis of TILRAY BRANDS INC TLRY Guru Analysis TLRY Fundamental Analysis ADAPTHEALTH CORP (AHCO) is a small-cap growth stock in the Medical Equipment & Supplies industry. The Company is primarily focused on providing sleep therapy equipment, supplies and related services, including CPAP and bi PAP services t... | The following are the top rated Health Care stocks according to Validea's Book/Market Investor model based on the published strategy of Joseph Piotroski. The Company conducts its business in one segment that provides its medical device products to healthcare providers and patients globally with manufacturing facilities... |
45727.0 | 2023-12-10 00:00:00 UTC | Validea's Top Health Care Stocks Based On Motley Fool - 12/10/2023 | ACGLO | https://www.nasdaq.com/articles/valideas-top-health-care-stocks-based-on-motley-fool-12-10-2023 | nan | nan | The following are the top rated Health Care stocks according to Validea's Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks with solid fundamentals and strong price performance.
POINT BIOPHARMA GLOBAL INC (PNT) is a small-cap growth stock in ... | The Company is focused on transforming precision medicine by combining a portfolio of radiopharmaceutical assets, a seasoned management team, a pipeline, in-house manufacturing capabilities, and secured supply for rare medical isotopes like actinium-225 (Ac) and lutetium-177 (Lu). Its RxSight system helps the surgeon p... | Detailed Analysis of POINT BIOPHARMA GLOBAL INC PNT Guru Analysis PNT Fundamental Analysis EYEPOINT PHARMACEUTICALS INC (EYPT) is a small-cap growth stock in the Biotechnology & Drugs industry. Detailed Analysis of EYEPOINT PHARMACEUTICALS INC EYPT Guru Analysis EYPT Fundamental Analysis RXSIGHT INC (RXST) is a small-c... | Detailed Analysis of POINT BIOPHARMA GLOBAL INC PNT Guru Analysis PNT Fundamental Analysis EYEPOINT PHARMACEUTICALS INC (EYPT) is a small-cap growth stock in the Biotechnology & Drugs industry. Detailed Analysis of EYEPOINT PHARMACEUTICALS INC EYPT Guru Analysis EYPT Fundamental Analysis RXSIGHT INC (RXST) is a small-c... | The following are the top rated Health Care stocks according to Validea's Small-Cap Growth Investor model based on the published strategy of Motley Fool. Its Lu-PNT2003 is a late-stage somatostatin-targeted radioligand in development for the treatment of neuroendocrine tumors. Detailed Analysis of RXSIGHT INC RXST Guru... |
45728.0 | 2023-12-10 00:00:00 UTC | Validea's Top Health Care Stocks Based On Kenneth Fisher - 12/10/2023 | ACGLO | https://www.nasdaq.com/articles/valideas-top-health-care-stocks-based-on-kenneth-fisher-12-10-2023 | nan | nan | The following are the top rated Health Care stocks according to Validea's Price/Sales Investor model based on the published strategy of Kenneth Fisher. This value strategy rewards stocks with low P/S ratios, long-term profit growth, strong free cash flow and consistent profit margins.
DOCGO INC (DCGO) is a small-cap gr... | The following are the top rated Health Care stocks according to Validea's Price/Sales Investor model based on the published strategy of Kenneth Fisher. Home Health provides services to individuals who require assistance during an illness or after hospitalization and includes skilled nursing and physical, occupational a... | Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria. Detailed Analysis of DOCGO INC DCGO Guru Analysis DCGO Fundamental Analysis ADDUS HOMECARE CORPORATION (ADUS) i... | The following are the top rated Health Care stocks according to Validea's Price/Sales Investor model based on the published strategy of Kenneth Fisher. Hospice Segment provides physical, emotional and spiritual care for people who are ill. Its hospice services include palliative nursing care, spiritual counseling, home... | Company Description: DocGo Inc. is a healthcare transportation and mobile services company. Its segments include Transportation Services and Mobile Health Services. The Company' segments include Personal Care, Hospice, and Home Health. |
45729.0 | 2023-12-10 00:00:00 UTC | Is Tesla Stock a Buy? | ACGLO | https://www.nasdaq.com/articles/is-tesla-stock-a-buy-9 | nan | nan | It seems as though Elon Musk, Tesla's (NASDAQ: TSLA) visionary founder and CEO, is always making headlines for one reason or another.
Despite what you think about him, though, Tesla's stock has been one of the biggest winners in recent memory.
But do shares make for a smart investment right now? Let's look at the elect... | Valuation analysis The presence of an economic moat, as well as growth potential in the EV industry, might nudge some investors into owning Tesla stock. On the other hand, the recent challenges facing the business point to how dependent Tesla is on a favorable macroeconomic backdrop, particularly related to interest ra... | For comparison's sake, Ford's and General Motors' gross margins have averaged less than 15% during the same time. Valuation analysis The presence of an economic moat, as well as growth potential in the EV industry, might nudge some investors into owning Tesla stock. The Motley Fool recommends General Motors and recomme... | Growth prospects Tesla shares have been a huge winner for investors mainly due to the company's incredible growth. Valuation analysis The presence of an economic moat, as well as growth potential in the EV industry, might nudge some investors into owning Tesla stock. On the other hand, the recent challenges facing the ... | But do shares make for a smart investment right now? Tesla is almost synonymous with the EV industry. Valuation analysis The presence of an economic moat, as well as growth potential in the EV industry, might nudge some investors into owning Tesla stock. |
45730.0 | 2023-12-10 00:00:00 UTC | 2 Major Risks Investors Should Know Before Buying Global-e's Stock | ACGLO | https://www.nasdaq.com/articles/2-major-risks-investors-should-know-before-buying-global-es-stock | nan | nan | Global-e Online (NASDAQ: GLBE) has been firing on all cylinders lately, delivering a 43% increase in revenue and a 76% jump in adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) in the first nine months of 2023. Similarly, the stock price has increased by more than 70% since the beginning o... | Global-e Online (NASDAQ: GLBE) has been firing on all cylinders lately, delivering a 43% increase in revenue and a 76% jump in adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) in the first nine months of 2023. The lack of historical data makes it difficult to assess Global-e's long-term p... | In short, Global-e's short track record makes analyzing it a challenging task. While this principle applies to every stock investment, it is even more relevant when investing in an unprofitable young company with a short track record like Global-e. And herein lies my other primary concern, which is Global-e's high valu... | Global-e's track record as a public company is relatively short Global-e has been one of the fastest-growing e-commerce companies, more than tripling its revenue from $136 million in 2020 to $409 million in 2022. The stock trades at a premium valuation According to Benjamin Graham, the father of value investing, invest... | The only caveat here is that Global-e has already achieved positive adjusted EBITDA, offering hope that becoming profitable is the natural next step for the company. While this principle applies to every stock investment, it is even more relevant when investing in an unprofitable young company with a short track record... |
45731.0 | 2023-12-10 00:00:00 UTC | 1 Artificial Intelligence (AI) Stock Set to Join Apple, Amazon, Microsoft, Alphabet, and Nvidia in the $1 Trillion Club | ACGLO | https://www.nasdaq.com/articles/1-artificial-intelligence-ai-stock-set-to-join-apple-amazon-microsoft-alphabet-and-nvidia | nan | nan | Every company in the $1 trillion club is investing heavily in artificial intelligence (AI).
Apple (NASDAQ: AAPL) touted several AI-powered features in its latest iOS update and new iPhone release. The company pours around $1 billion annually into developing new AI technologies.
Amazon (NASDAQ: AMZN) is the leading clou... | It should be no surprise, then, that one of the most promising stocks to join the group with market caps exceeding $1 trillion is also spending heavily to develop artificial intelligence and apply it to its products. "AI will be our biggest investment area in 2024 -- both in engineering and compute resources," he told ... | Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) is developing its own large language model to power its services and provides a cloud computing platform for developers to train and run their own AI applications. Pushing generative AI forward Meta CEO Mark Zuckerberg has practically transformed his company from a social media p... | Microsoft (NASDAQ: MSFT) positioned itself as a top choice for AI developers when it increased its investment in OpenAI earlier this year, garnering a 49% stake in the leading AI developer. In fact, there might not be anyone developing an AI as advanced as Meta Platform's (NASDAQ: META), and the market may be underappr... | Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) is developing its own large language model to power its services and provides a cloud computing platform for developers to train and run their own AI applications. Meta also uses generative AI to help businesses craft more effective advertisements on Facebook and Instagram. Apple... |
45732.0 | 2023-12-10 00:00:00 UTC | Value Picks: 3 Undervalued Stocks Ready to Rebound | ACGLO | https://www.nasdaq.com/articles/value-picks%3A-3-undervalued-stocks-ready-to-rebound | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Before getting into a discussion about value stocks, it’s important to point out what the label isn’t. Whenever a security – or anything for that matter – goes on sale, you must ask yourself why. If demand was robust to the point of overflowing, there would... | As the world’s largest equipment rental company, United offers enterprises a mechanism for business expansion without a heavy commitment to acquiring additional assets. Over the past several years, he has delivered unique, critical insights for the investment markets, as well as various other industries including legal... | Penske Automotive Group (PAG) Source: Jonathan Weiss / Shutterstock.com On the surface, Penske Automotive Group (NYSE:PAG) doesn’t appear a natural candidate for value stocks. United Rentals (URI) Source: Casimiro PT / Shutterstock.com Moving over to United Rentals (NYSE:URI), the company makes a bit more intuitive sen... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Before getting into a discussion about value stocks, it’s important to point out what the label isn’t. Penske Automotive Group (PAG) Source: Jonathan Weiss / Shutterstock.com On the surface, Penske Automotive Group (NYSE:PAG) doesn’t appear a natural candid... | Penske’s revenue continues to increase since 2020 but more importantly, the erosion of gross margin is arguably within acceptable ranges. In conclusion, PAG’s low earnings multiple of 8.92x is relatively credible, making it one of the genuinely undervalued stocks. Now, EXP isn’t the most discounted among undervalued st... |
45733.0 | 2023-12-10 00:00:00 UTC | Validea's Top Health Care Stocks Based On Benjamin Graham - 12/10/2023 | ACGLO | https://www.nasdaq.com/articles/valideas-top-health-care-stocks-based-on-benjamin-graham-12-10-2023 | nan | nan | The following are the top rated Health Care stocks according to Validea's Value Investor model based on the published strategy of Benjamin Graham. This deep value methodology screens for stocks that have low P/B and P/E ratios, along with low debt and solid long-term earnings growth.
MODERNA INC (MRNA) is a large-cap s... | mRNA medicines are designed to direct the body's cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range spectrum of diseases. Graham built his fortune and reputation after living through some extremely difficult times, including... | Detailed Analysis of REGENERON PHARMACEUTICALS INC REGN Guru Analysis REGN Fundamental Analysis EDWARDS LIFESCIENCES CORP (EW) is a large-cap growth stock in the Medical Equipment & Supplies industry. Detailed Analysis of EDWARDS LIFESCIENCES CORP EW Guru Analysis EW Fundamental Analysis FULGENT GENETICS INC (FLGT) is ... | The Company's commercialized medicines and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases and rare diseases. Its therapeutic development business is fo... | Company Description: Moderna, Inc. is a biotechnology company. It is also advancing a pipeline of preclinical product candidates and discovery-stage programs in oncology (including immuno-oncology agents) and other therapeutic areas with an emphasis on developing ADC and multi-specific antibody therapeutics (MSAT) cand... |
45734.0 | 2023-12-10 00:00:00 UTC | 3 Overlooked Industrial Stocks Set to Skyrocket in the Next Decade | ACGLO | https://www.nasdaq.com/articles/3-overlooked-industrial-stocks-set-to-skyrocket-in-the-next-decade | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
The world of U.S. industrial stocks is changing fast, with some parts that people often don’t pay much attention to now becoming great choices for investing. Companies that provide services to industries are getting better by using more technology. This was... | Delving into Grainger’s latest financial reports, the third-quarter numbers reveal a substantial revenue upswing, climbing to $4.21 billion, marking a 7% increase from the previous year. These collective developments underscore W.W. Grainger’s sturdy financial standing and strategic direction, solidifying its status as... | This financial restructuring has enhanced its cash flow, with a remarkable 250% increase in net change in cash, showcasing Graco’s robust operational efficiency. Badger Meter (BMI) Source: Pavel Kapysh / Shutterstock.com Badger Meter (NYSE:BMI), a notable player in the industrial sector, has been turning heads with its... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips The world of U.S. industrial stocks is changing fast, with some parts that people often don’t pay much attention to now becoming great choices for investing. This financial restructuring has enhanced its cash flow, with a remarkable 250% increase in net cha... | The company’s YTD return stands at a robust 35%. Net income soared by 45%, reaching $26 million, showcasing the company’s efficient operations and strong market demand. Grainger’s earnings per share also mirror its robust financial performance, showing a 14% increase to $9.43. |
45735.0 | 2023-12-10 00:00:00 UTC | Weekly Preview: Earnings to Watch This Week 12-10-23 (ADBE, ORCL) | ACGLO | https://www.nasdaq.com/articles/weekly-preview-earnings-to-watch-this-week-12-10-23-adbe-orcl | nan | nan | A
stronger-than-expected jobs report, which typically sparks fears of an aggressive Fed, couldn’t keep the S&P 500 index from surging to new highs on Friday. Investors digested the University of Michigan consumer survey, which suggests not only is the economy heading in the right direction, but also the likelihood of a... | Investors digested the University of Michigan consumer survey, which suggests not only is the economy heading in the right direction, but also the likelihood of a “soft landing” is closer than economists expected. Just as important, average hourly earnings, rose as expected in November, which matches the increased job ... | As for the labor supply-and-demand dynamic, November’s job report revealed a decline in the unemployment rate, falling to 3.7% from the prior month's 3.9%. Despite recent questions about the Q4 guidance for Digital Media revenue, adoption for Firefly, Weiss believes investors should feel "very comfortable" with the com... | What to watch: Oracle stock has not enjoyed the sort of momentum we have witnessed in other software stocks which have skyrocketed amid excitement over AI. What to watch: Fueled by momentum of artificial intelligence, Adobe stock has surged 44% in the past six months, ranking highly in the basket of software stocks tha... | As for the labor supply-and-demand dynamic, November’s job report revealed a decline in the unemployment rate, falling to 3.7% from the prior month's 3.9%. The S&P 500 rose by 0.41%, closing at 4,604.37. Over the past three months, Oracle has suffered a 10% decline in the share price, while the S&P 500 index has risen ... |
45736.0 | 2023-12-10 00:00:00 UTC | Of Geniuses and Dummies: Navigating Through Tough Times in the Market | ACGLO | https://www.nasdaq.com/articles/of-geniuses-and-dummies%3A-navigating-through-tough-times-in-the-market | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Editor’s Note: On Tuesday, December 12, at 7 p.m. Eastern time, Eric Fry, Luke Lango and I are gathering for a special event – the Early Warning Summit 2024 – to give you their investing game plan for 2024. It’s a strategy that could outperform the market b... | So, on December 12, at 7 p.m. Eastern time, I will be sitting down with Louis Navellier and Luke Lango for a special Early Warning Summit 2024, where we’ll lay out our investing playbook for the New Year. It’s a unique approach, but it gave a small group of our fellow readers the chance to beat the Dow Jones Industrial... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Editor’s Note: On Tuesday, December 12, at 7 p.m. Eastern time, Eric Fry, Luke Lango and I are gathering for a special event – the Early Warning Summit 2024 – to give you their investing game plan for 2024. So, on December 12, at 7 p.m. Eastern time, I will... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Editor’s Note: On Tuesday, December 12, at 7 p.m. Eastern time, Eric Fry, Luke Lango and I are gathering for a special event – the Early Warning Summit 2024 – to give you their investing game plan for 2024. Ahead of the event, I wanted to share a great arti... | Only one of the 11 sectors that make up the S&P 500 index has produced a gain since the end of 2021. Even the high-profile names that have produced heroic performances this year are showing losses over the last two years. Although there have been some winners since 2021, the stock market has been distributing more pain... |
45737.0 | 2023-12-10 00:00:00 UTC | Blackrock Inc. Shares Near 52-Week High - Market Mover | ACGLO | https://www.nasdaq.com/articles/blackrock-inc.-shares-near-52-week-high-market-mover | nan | nan | Blackrock Inc. (BLK) shares closed today at 1.0% below its 52 week high of $759.86, giving the company a market cap of $110B. The stock is currently up 8.1% year-to-date, up 8.4% over the past 12 months, and up 115.9% over the past five years. This week, the Dow Jones Industrial Average rose 0.0%, and the S&P 500 rose ... | Blackrock Inc. (BLK) shares closed today at 1.0% below its 52 week high of $759.86, giving the company a market cap of $110B. Beta, a measure of the stock’s volatility relative to the overall market stands at 1.2. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1... | Blackrock Inc. (BLK) shares closed today at 1.0% below its 52 week high of $759.86, giving the company a market cap of $110B. This week, the Dow Jones Industrial Average rose 0.0%, and the S&P 500 rose 0.2%. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year ... | Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same ... | This week, the Dow Jones Industrial Average rose 0.0%, and the S&P 500 rose 0.2%. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year bas... |
45738.0 | 2023-12-10 00:00:00 UTC | AstraZeneca : Phase III Trial Data Show Danicopan Sustained Clinical Improvements In PNH | ACGLO | https://www.nasdaq.com/articles/astrazeneca-%3A-phase-iii-trial-data-show-danicopan-sustained-clinical-improvements-in-pnh | nan | nan | (RTTNews) - AstraZeneca (AZN, AZN.L) said that positive results from the 24-week and long-term extension period of the pivotal ALPHA Phase III trial showed danicopan as add-on to standard of care C5 inhibitor therapy Ultomiris (ravulizumab-cwvz) or Soliris (eculizumab) continued to demonstrate clinical benefit for pati... | (RTTNews) - AstraZeneca (AZN, AZN.L) said that positive results from the 24-week and long-term extension period of the pivotal ALPHA Phase III trial showed danicopan as add-on to standard of care C5 inhibitor therapy Ultomiris (ravulizumab-cwvz) or Soliris (eculizumab) continued to demonstrate clinical benefit for pati... | (RTTNews) - AstraZeneca (AZN, AZN.L) said that positive results from the 24-week and long-term extension period of the pivotal ALPHA Phase III trial showed danicopan as add-on to standard of care C5 inhibitor therapy Ultomiris (ravulizumab-cwvz) or Soliris (eculizumab) continued to demonstrate clinical benefit for pati... | (RTTNews) - AstraZeneca (AZN, AZN.L) said that positive results from the 24-week and long-term extension period of the pivotal ALPHA Phase III trial showed danicopan as add-on to standard of care C5 inhibitor therapy Ultomiris (ravulizumab-cwvz) or Soliris (eculizumab) continued to demonstrate clinical benefit for pati... | Data showed that improvements in mean hemoglobin levels and absolute reticulocyte count (ARC) levels, which were demonstrated at 12 weeks, were maintained through 48 weeks. All key secondary endpoints met superiority in favor of danicopan plus ULTOMIRIS or SOLIRIS compared to placebo plus ULTOMIRIS or SOLIRIS at 12 wee... |
45739.0 | 2023-12-10 00:00:00 UTC | 4 Top Dividend Stocks Yielding More Than 4% to Buy Hand-Over-Fist This December | ACGLO | https://www.nasdaq.com/articles/4-top-dividend-stocks-yielding-more-than-4-to-buy-hand-over-fist-this-december | nan | nan | Many dividend stocks have sold off over the past year. Higher interest rates made lower-risk investments like bonds and bank CDs more attractive income-generating options. That weighed on the value of some high-quality dividend stocks, pushing up their yields.
On the bright side, income-seeking investors can lock in so... | The company's latest dividend increase "underscore[s] our confidence in AbbVie's long-term outlook," stated CEO Richard Gonzales in the third-quarter earnings release. The company's growth-focused investments should help drive its revenue higher over the long term, enabling AbbVie to continue increasing its attractive ... | Realty Income (NYSE: O), Brookfield Renewable (NYSE: BEPC)(NYSE: BEP), AbbVie (NYSE: ABBV), and Verizon (NYSE: VZ) all currently offer dividend yields above 4%, which is more than double the S&P 500's yield (1.5%). Great income investments to stock up on this month Realty Income, Brookfield Renewable, AbbVie, and Veriz... | Realty Income (NYSE: O), Brookfield Renewable (NYSE: BEPC)(NYSE: BEP), AbbVie (NYSE: ABBV), and Verizon (NYSE: VZ) all currently offer dividend yields above 4%, which is more than double the S&P 500's yield (1.5%). Great income investments to stock up on this month Realty Income, Brookfield Renewable, AbbVie, and Veriz... | The company's growth-focused investments should help drive its revenue higher over the long term, enabling AbbVie to continue increasing its attractive dividend. Great income investments to stock up on this month Realty Income, Brookfield Renewable, AbbVie, and Verizon pay very attractive dividends these days. Should y... |
45740.0 | 2023-12-10 00:00:00 UTC | Get Ready for 2024 With These 3 Dividend Stocks | ACGLO | https://www.nasdaq.com/articles/get-ready-for-2024-with-these-3-dividend-stocks | nan | nan | With inflation driving up expenses, many people are searching for ways to boost their income these days. One option is to make investments geared toward generating passive income. That could set you up to make more money next year to help offset some of inflation's sting.
Stanley Black & Decker (NYSE: SWK), Energy Tran... | For example, operating margin in the company's tools and outdoor division, its most important business, have been heading higher for three consecutive quarters as management's efforts to boost profitability take hold. Add some expansion project catalysts, and it's a great dividend stock to buy to position your portfoli... | Stanley Black & Decker (NYSE: SWK), Energy Transfer (NYSE: ET), and Brookfield Infrastructure Partners (NYSE: BIPC)(NYSE: BIP) stand out to a few Fool.com contributors as great income options for 2024. Stanley Black & Decker's turnaround is progressing Reuben Gregg Brewer (Stanley Black & Decker): There's no point suga... | This stock should give you a dividend raise in 2024 Neha Chamaria (Brookfield Infrastructure Partners): Shares of Brookfield Infrastructure -- both the partnership and corporate shares -- have lost more than a quarter of their value in the past six months or so. Before you buy stock in Energy Transfer, consider this: T... | This stock should give you a dividend raise in 2024 Neha Chamaria (Brookfield Infrastructure Partners): Shares of Brookfield Infrastructure -- both the partnership and corporate shares -- have lost more than a quarter of their value in the past six months or so. Before you buy stock in Energy Transfer, consider this: T... |
45741.0 | 2023-12-10 00:00:00 UTC | One Stock That Will Snag You Over $1,000 in Dividends per Year -- Just Invest This Amount | ACGLO | https://www.nasdaq.com/articles/one-stock-that-will-snag-you-over-%241000-in-dividends-per-year-just-invest-this-amount | nan | nan | Are you looking for above-average investment income, but don't have a ton of idle cash to work with? It's a tall order to be sure. See, investing is ultimately about trade-offs. Reliable dividend-paying stocks generally don't sport sky-high yields, for instance, just as growth stocks generally don't pay significant div... | The so-called yield curve's inversion seen back in 2019 also works against mortgage REITs, by driving their short-term borrowing costs above the interest rates on the longer-term loans they're buying. The combination of these headwinds is a big reason AGNC Investment lowered its dividend back in 2019 and again in 2020,... | This type of real estate investment trust doesn't own any actual real estate, but rather, it owns bundles of mortgage loans. The so-called yield curve's inversion seen back in 2019 also works against mortgage REITs, by driving their short-term borrowing costs above the interest rates on the longer-term loans they're bu... | The so-called yield curve's inversion seen back in 2019 also works against mortgage REITs, by driving their short-term borrowing costs above the interest rates on the longer-term loans they're buying. It's possible all interest rates will linger at levels that are disadvantageous to mortgage REITs like AGNC Investment.... | And AGNC Investment continues to make its monthly dividend payments in the meantime, rewarding patient shareholders who can stomach the volatility. Should you invest $1,000 in AGNC Investment Corp. right now? Before you buy stock in AGNC Investment Corp., consider this: The Motley Fool Stock Advisor analyst team just i... |
45742.0 | 2023-12-10 00:00:00 UTC | Is Apple Stock a Buy for 2024? | ACGLO | https://www.nasdaq.com/articles/is-apple-stock-a-buy-for-2024 | nan | nan | Apple (NASDAQ: AAPL) shareholders have had a great 2023. The stock has gained 50% through early December and is sitting near its all-time highs as the year draws to a close.
Investors have good reasons to be excited about the tech giant's growth prospects over the next several years. But much of that optimism is alread... | Its Mac and iPad sales are down over the past year, and the iPhone business only recently returned to expansion in the fiscal Q4 period that ran through late September. That impressive portfolio is a big reason why most Wall Street pros predict modest sales growth this year, along with a larger 6% increase in fiscal 20... | Apple generated $114 billion of operating earnings in the past year, landing its margin at nearly 20% of sales. Thanks to its highly efficient global business, industry-leading profit margins, and the ongoing tilt toward services sales, Apple generates well over $100 billion a year in operating cash flow. See the 10 st... | Apple is tapping into loyalty to maintain profits While sales trends slowed a bit, Apple hasn't lost any ground on the critical customer satisfaction metric that powers long-term growth. Cash returns suggest a positive outlook for Apple Owning Apple stock in 2024 will almost certainly mean more cash is headed your way.... | Apple generated $114 billion of operating earnings in the past year, landing its margin at nearly 20% of sales. Thanks to its highly efficient global business, industry-leading profit margins, and the ongoing tilt toward services sales, Apple generates well over $100 billion a year in operating cash flow. See the 10 st... |
45743.0 | 2023-12-10 00:00:00 UTC | 3 No-Brainer Cryptos to Buy Before the End of 2023 | ACGLO | https://www.nasdaq.com/articles/3-no-brainer-cryptos-to-buy-before-the-end-of-2023 | nan | nan | With the crypto market showing signs of heating up once again, it's time to look for high-upside cryptocurrencies with the potential to skyrocket even higher. The focus here should be on cryptos with solid, long-term growth prospects that can be added to a diversified buy-and-hold portfolio.
With that in mind, I've pic... | What this means in practical terms is that they are the fundamental building blocks for everything that takes place in the blockchain world, from non-fungible tokens (NFTs) to decentralized finance (DeFi). According to investment firm VanEck, Solana only has to achieve a 30% market share in three key blockchain niches ... | With that in mind, I've picked out three no-brainer cryptos to buy before the end of the year: Bitcoin (CRYPTO: BTC), Solana (CRYPTO: SOL), and XRP (CRYPTO: XRP). By estimating Solana's future market share in several key blockchain niches, it's possible to arrive at an estimate of Solana's future valuation. So the reas... | With that in mind, I've picked out three no-brainer cryptos to buy before the end of the year: Bitcoin (CRYPTO: BTC), Solana (CRYPTO: SOL), and XRP (CRYPTO: XRP). While XRP's performance this year doesn't jump off the page the way Bitcoin's or Solana's performance does, it could end up being a bigger winner over the lo... | With that in mind, I've picked out three no-brainer cryptos to buy before the end of the year: Bitcoin (CRYPTO: BTC), Solana (CRYPTO: SOL), and XRP (CRYPTO: XRP). For the year, Bitcoin is now up more than 160%. Due to Bitcoin's increasingly important role in the global financial system, adoption of Bitcoin is now at an... |
45744.0 | 2023-12-10 00:00:00 UTC | AstraZeneca Just Joined the AI Drug Development Craze, but Is It a Buy in 2024? | ACGLO | https://www.nasdaq.com/articles/astrazeneca-just-joined-the-ai-drug-development-craze-but-is-it-a-buy-in-2024 | nan | nan | It's hard to see a presentation or read a press release by a major pharmaceutical company these days without hearing about how they're planning to use artificial intelligence (AI) to supercharge their drug development efforts -- and AstraZeneca's (NASDAQ: AZN) materials are no different.
But will using the rapidly adva... | It's hard to see a presentation or read a press release by a major pharmaceutical company these days without hearing about how they're planning to use artificial intelligence (AI) to supercharge their drug development efforts -- and AstraZeneca's (NASDAQ: AZN) materials are no different. In September, it committed to p... | On Dec. 4, the company announced that it was teaming up with Absci, an AI drug discovery biotech, to develop an antibody intended for use in treating cancer. While this marks a significant acceleration of AstraZeneca's efforts, the deal with Absci isn't the pharma's first attempt at dabbling with AI for research and de... | It's hard to see a presentation or read a press release by a major pharmaceutical company these days without hearing about how they're planning to use artificial intelligence (AI) to supercharge their drug development efforts -- and AstraZeneca's (NASDAQ: AZN) materials are no different. On Dec. 4, the company announce... | On Dec. 4, the company announced that it was teaming up with Absci, an AI drug discovery biotech, to develop an antibody intended for use in treating cancer. Is AI enough to make AstraZeneca a buy? That's right -- they think these 10 stocks are even better buys. |
45745.0 | 2023-12-10 00:00:00 UTC | My Top Under-Appreciated Growth Stock to Buy in December and Hold for Decades | ACGLO | https://www.nasdaq.com/articles/my-top-under-appreciated-growth-stock-to-buy-in-december-and-hold-for-decades | nan | nan | Rivian Automotive (NASDAQ: RIVN) went public at the perfect time. Optimism was high as the worst of the COVID-19 pandemic seemed over. The venture capital and initial public offering (IPO) markets were flush with cash. And on Nov. 10, 2021, Rivian had its IPO, shooting up to a staggering intraday high of $179.47 per sh... | For now, Rivian's 4.3 price-to-sales (P/S) ratio looks fairly inexpensive for a company that could be growing sales by over 50% and posting positive gross margins next year. Long-term investors confident in Rivian's three-to-five-year plan can sit back and monitor its key metrics. All told, Rivian deserves a lot of cre... | Rivian finished the year with production of 24,337 vehicles and $11.6 billion in cash and cash equivalents. In its Q3 2023 shareholder letter, Rivian updated its full-year production guidance to 54,000 vehicles, an adjusted EBITDA loss of $4 billion, and just $1.1 billion in capex -- showing the company's ability to cu... | Delivering on promises Rivian (the stock) may have gone public at the perfect time, but 2022 proved to be extremely challenging for Rivian as a company. Rivian stock is worth buying now Rivian has clear and defined expectations for 2024. If Rivian grows sales growth and the stock price doesn't rise, it will further com... | Rivian finished the year with production of 24,337 vehicles and $11.6 billion in cash and cash equivalents. Rivian stock is worth buying now Rivian has clear and defined expectations for 2024. If Rivian grows sales growth and the stock price doesn't rise, it will further compress its P/S ratio and make Rivian a better ... |
45746.0 | 2023-12-10 00:00:00 UTC | What AT&T Investors Need to Know About the $14 Billion Open RAN Deal | ACGLO | https://www.nasdaq.com/articles/what-att-investors-need-to-know-about-the-%2414-billion-open-ran-deal | nan | nan | Telecom giant AT&T (NYSE: T) is embarking on a revamp of its wireless network infrastructure. The company announced last week that it had signed a deal with Sweden's Ericsson to spend as much as $14 billion over five years to deploy open radio access network, or Open RAN, technology.
Within a wireless network, the RAN ... | By adopting Open RAN technology, AT&T will have the ability to mix and match suppliers and build a highly flexible network that is potentially more cost-efficient. AT&T is planning to pass 30 million locations with its fiber network by the end of 2025, but there may be room to boost that target higher thanks to the Ope... | AT&T stock is a buy, Open RAN or not The Open RAN deal isn't a reason to pile into AT&T stock, but a rock-bottom valuation, solid performance in the wireless business, and a sky-high dividend certainly are. With AT&T expecting to generate around $16.5 billion of free cash flow this year, the stock trades for just over ... | The company announced last week that it had signed a deal with Sweden's Ericsson to spend as much as $14 billion over five years to deploy open radio access network, or Open RAN, technology. AT&T stock is a buy, Open RAN or not The Open RAN deal isn't a reason to pile into AT&T stock, but a rock-bottom valuation, solid... | By making its wireless capital spending go further by adopting Open RAN, any savings could be reallocated to expanding the fiber network . AT&T is making a forward-thinking decision to revamp its wireless network with Open RAN technology. Before you buy stock in AT&T, consider this: The Motley Fool Stock Advisor analys... |
45747.0 | 2023-12-10 00:00:00 UTC | Cash App Is the Most-Used Investing App Across All Generations. Does That Make Block a Buy? | ACGLO | https://www.nasdaq.com/articles/cash-app-is-the-most-used-investing-app-across-all-generations.-does-that-make-block-a-buy | nan | nan | Investors have numerous options when it comes to investment platforms. Those who have invested in index funds or traded stocks for several years may turn to a Charles Schwab or a Fidelity. Younger investors often gravitate toward Robinhood, while more cryptocurrency-oriented investors may prefer Coinbase.
However, when... | However, when it comes to the most trusted platform, it will likely surprise many that it is Cash App, the digital wallet operated by its parent company, Block (NYSE: SQ). Investing in Cash App Moreover, investors can buy into this story -- if they are also willing to assess the Square ecosystem and the performance of ... | Nonetheless, the company's rising revenue has narrowed its losses meaningfully, increasing the likelihood of profits in the foreseeable future. The Motley Fool has positions in and recommends Bitcoin, Block, and Coinbase Global. The Motley Fool recommends Charles Schwab and recommends the following options: short Decem... | Assessing Cash App According to The Motley Fool's Generational Investing Tools survey, 38% of respondents use Cash App for investing purposes, and it is particularly profitable among Gen Z and millennial investors. Indeed, Block reported about $2.9 billion in gross profit for Cash App in the first nine months of 2023, ... | Still, Cash App made up only 53% of the company's $5.5 billion in gross profits. Should I buy Block for its Cash App success? The Motley Fool has positions in and recommends Bitcoin, Block, and Coinbase Global. |
45748.0 | 2023-12-10 00:00:00 UTC | DocuSign Is on Track for Its First Profitable Year in Its History. Is It Time to Buy DocuSign Stock? | ACGLO | https://www.nasdaq.com/articles/docusign-is-on-track-for-its-first-profitable-year-in-its-history.-is-it-time-to-buy | nan | nan | We are now far removed from the worst of the COVID-19 pandemic, and for companies like DocuSign (NASDAQ: DOCU), that requires a substantial transition. The leader in e-signature and digital document technology experienced soaring growth in the work-from-home economy, but now it's focusing on building a more sustainable... | The leader in e-signature and digital document technology experienced soaring growth in the work-from-home economy, but now it's focusing on building a more sustainable business. DocuSign serves its customers at every step of the agreement journey, including drafting, negotiating, identity verification, and signing -- ... | That means managing costs more carefully to achieve profitability, which has eluded the company since it went public in 2018. But the company has expanded significantly from that one-dimensional business; its Agreement Cloud platform now features more than 12 applications designed to help businesses manage different pa... | DocuSign remains a key technology provider for millions of businesses DocuSign is a pioneer of the e-signature industry, and it stands alone as the largest player to this day. DocuSign is tracking for its first profitable year Losing money is a feature of many modern technology companies, especially in their growth pha... | That means managing costs more carefully to achieve profitability, which has eluded the company since it went public in 2018. DocuSign is tracking for its first profitable year Losing money is a feature of many modern technology companies, especially in their growth phase. Before you buy stock in DocuSign, consider thi... |
45749.0 | 2023-12-10 00:00:00 UTC | 3 Monster Dividend Stocks to Buy Before the New Year | ACGLO | https://www.nasdaq.com/articles/3-monster-dividend-stocks-to-buy-before-the-new-year | nan | nan | 2023 has been a banner year for the stock market, particularly for megacap growth stocks. But many passive income investors may feel like they've missed out on the epic rally.
High-yield sectors, such as energy and utilities, have underperformed the major indices. But there's reason to believe the underperformance pres... | Exxon has consistently been against drastic investments in renewable energy, choosing instead to stay within its core competency of manipulating the hydrocarbon chain. The longer-term answer is one all investors must consider because the future role of natural gas in the economy is open to debate, given the growth of r... | Kinder Morgan just raised its dividend expectations Lee Samaha (Kinder Morgan): It's not difficult to see the attraction of the North American energy infrastructure's dividend. Put a jolt in your passive income with American Electric Power Scott Levine (American Electric Power): They may not have the razzle of disrupti... | Kinder Morgan just raised its dividend expectations Lee Samaha (Kinder Morgan): It's not difficult to see the attraction of the North American energy infrastructure's dividend. For those looking to scare up some passive income with a monster dividend stock, American Electric Power -- and its forward-yielding 4.4% divid... | Exxon understands that oil and gas has to become a cleaner industry if it will play a role in the energy transition. Management recently told investors it expects to grow its distributable cash flow by 5% in 2024 and its dividend per share by 2% to $1.15, putting its yearly dividend yield at slightly above 6.5% based o... |
45750.0 | 2023-12-10 00:00:00 UTC | Could Aurora Cannabis Be a Screaming Buy Right Now? | ACGLO | https://www.nasdaq.com/articles/could-aurora-cannabis-be-a-screaming-buy-right-now | nan | nan | With a share price down 99.5% from its early 2019 highs, $225 million in sales, and $818 million in annual losses, on the surface at least, Canadian marijuana stock Aurora Cannabis (NASDAQ: ACB) stock does not look much like a screaming buy right now.
But a lot of things could change for Aurora Cannabis in 2024.
And if... | With management forecasting Q3 revenue "largely similar" to Q2, furthermore, Aurora will probably lose at least a little money next quarter as well -- unless cost-cutting saves the day. Indeed, Aurora Cannabis management is on record promising to deliver positive free cash flow next year, and if it does that, actual GA... | With a share price down 99.5% from its early 2019 highs, $225 million in sales, and $818 million in annual losses, on the surface at least, Canadian marijuana stock Aurora Cannabis (NASDAQ: ACB) stock does not look much like a screaming buy right now. Operating costs for the company in fiscal Q2 were $27.6 million, eat... | With a share price down 99.5% from its early 2019 highs, $225 million in sales, and $818 million in annual losses, on the surface at least, Canadian marijuana stock Aurora Cannabis (NASDAQ: ACB) stock does not look much like a screaming buy right now. Operating costs for the company in fiscal Q2 were $27.6 million, eat... | And if these things do change, then now really might be the right time to buy Aurora Cannabis. They think the company will lose money next year as well ($0.03 per share) and only break even in fiscal 2026 -- before finally earning a profit, according to generally accepted accounting principles (GAAP), of $0.03 per shar... |
45751.0 | 2023-12-10 00:00:00 UTC | Google's Gemini AI Could Be a Game Changer | ACGLO | https://www.nasdaq.com/articles/googles-gemini-ai-could-be-a-game-changer | nan | nan | Since it was introduced late last year, OpenAI's ChatGPT and the GPT family of large language models that power it have been unbeatable. GPT-4, the most recent LLM from OpenAI, is largely considered the most capable generative AI model available.
Alphabet's (NASDAQ: GOOG)(NASDAQ: GOOGL) Google offers AI models of its o... | Since it was introduced late last year, OpenAI's ChatGPT and the GPT family of large language models that power it have been unbeatable. Built from the ground up to understand text, images, audio, and code, Google claims that Gemini beats GPT-4 across a wide range of AI benchmarks. A massive opportunity While estimates... | Alphabet's (NASDAQ: GOOG)(NASDAQ: GOOGL) Google offers AI models of its own, including the PaLM family of large language models. Third, Google's Android and Pixel smartphone businesses will benefit from Gemini Nano, the smallest of the three Gemini models. Gemini Nano will run directly on smartphones running Android 14... | Alphabet's (NASDAQ: GOOG)(NASDAQ: GOOGL) Google offers AI models of its own, including the PaLM family of large language models. Given how scarce and expensive Nvidia's most powerful data center GPUs have become as the AI frenzy picks up steam, Google's use of custom AI chips could give it an important cost advantage a... | GPT-4, the most recent LLM from OpenAI, is largely considered the most capable generative AI model available. Third, Google's Android and Pixel smartphone businesses will benefit from Gemini Nano, the smallest of the three Gemini models. Before you buy stock in Alphabet, consider this: The Motley Fool Stock Advisor ana... |
45752.0 | 2023-12-10 00:00:00 UTC | Is Upstart Stock a Buy? | ACGLO | https://www.nasdaq.com/articles/is-upstart-stock-a-buy-9 | nan | nan | Upstart (NASDAQ: UPST) shareholders have been on a wild ride in recent years. That's because the company's financial results have been severely impacted by macro factors, although investors have bid up shares this year.
Even though this fintech stock has climbed 151% in 2023, the valuation, as measured by the price-to-... | In an effort to curb soaring inflation, the Federal Reserve embarked on the fastest rate-hiking campaign in history last year. Waiting on improvements I can see why some investors who focus their attention more on speculative growth stocks that have sizable potential over the long term might be compelled to take a clos... | The worst possible scenario Like nearly all other fintech companies, Upstart was experiencing boom times during the days of the coronavirus pandemic. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market. See the 10 stocks *Stock Advisor returns as of November 29, ... | 10 stocks we like better than Upstart When our analyst team has a stock tip, it can pay to listen. * They just revealed what they believe are the ten best stocks for investors to buy right now... and Upstart wasn't one of them! See the 10 stocks *Stock Advisor returns as of November 29, 2023 Neil Patel and his clients ... | That same year, in 2021, revenue surged 264%, thanks to Upstart's artificial intelligence (AI)-powered lending platform, which originated 338% more loans than in the prior year. Not only has the business already found a real-world use case for AI, but the fact that the total origination value of personal, auto, home, a... |
45753.0 | 2023-12-10 00:00:00 UTC | Where Will Teladoc Health Be in 5 Years? | ACGLO | https://www.nasdaq.com/articles/where-will-teladoc-health-be-in-5-years | nan | nan | The past three years have been a roller-coaster ride for Teladoc Health (NYSE: TDOC). The company initially rode a pandemic-induced high when its business was in high demand, but the telemedicine specialist has since lost much of that momentum -- along with the associated stock market gains.
However, Teladoc isn't dead... | The question is whether revenue growth will keep growing fast enough -- while marketing expenses decrease enough -- in the next half-decade for the company to turn a profit. Teladoc isn't worse off than before the pandemic started, yet its share price and market cap are substantially below what they were then. The inve... | TDOC data by YCharts The telemedicine market should keep growing The traction the telemedicine market gained during the early pandemic years may have slowed, but the entire industry should continue going up. Integrated care members increased by 10% year over year to 90.2 million, while BetterHelp and Chronic Care saw y... | TDOC data by YCharts The telemedicine market should keep growing The traction the telemedicine market gained during the early pandemic years may have slowed, but the entire industry should continue going up. In the third quarter, Teladoc's revenue of $660.2 million increased by 8% year over year. 10 stocks we like bett... | What will happen to the company throughout the next five years? The question is whether revenue growth will keep growing fast enough -- while marketing expenses decrease enough -- in the next half-decade for the company to turn a profit. * They just revealed what they believe are the ten best stocks for investors to bu... |
45754.0 | 2023-12-10 00:00:00 UTC | 2024 Tech Revolution: 3 Undervalued Stocks Set For Magnificent Growth -- Uncover Hidden Tech Treasures For the New Year | ACGLO | https://www.nasdaq.com/articles/2024-tech-revolution%3A-3-undervalued-stocks-set-for-magnificent-growth-uncover-hidden-tech | nan | nan | The tech sector is currently experiencing massive changes, sparked by the ChatGPT introduction and a stabilizing global economy. The stock market is also turning in a new direction, reflecting these secular market shifts on the fly.
Hidden at the bustling corner of Wall Street and Silicon Valley, three undervalued stoc... | In the fourth quarter, for example, the company landed expanded or brand new design wins with networking equipment giant Netgear (NASDAQ: NTGR) and several top-of-the-line Android smartphones. The Tensor G3 processor found at the heart of the Pixel 8 still includes a 5G modem, but bypassing that feature in favor of an ... | The chiplet era is upon us and Kulicke and Soffa will be a huge winner Billy Duberstein (Kulicke and Soffa): At its recent AI conference, Advanced Micro Devices (NASDAQ: AMD) CEO Lisa Su upped her 2027 forecast for AI accelerators significantly, from $150 billion to $400 billion, while calling out AI as having the fast... | TSMC stock trades for about 19 times next year's expected earnings per share, with upside if the top chip company can sustain its recent growth uptick. The chiplet era is upon us and Kulicke and Soffa will be a huge winner Billy Duberstein (Kulicke and Soffa): At its recent AI conference, Advanced Micro Devices (NASDAQ... | TSMC stock trades for about 19 times next year's expected earnings per share, with upside if the top chip company can sustain its recent growth uptick. That's up from 58% last year and 59% in 2021. Before you buy stock in Taiwan Semiconductor Manufacturing, consider this: The Motley Fool Stock Advisor analyst team just... |
45755.0 | 2023-12-10 00:00:00 UTC | Could This Underperforming Stock Become a Millionaire-Maker? | ACGLO | https://www.nasdaq.com/articles/could-this-underperforming-stock-become-a-millionaire-maker | nan | nan | Shares of Lumen Technologies (NYSE: LUMN) -- formerly CenturyLink up until late 2020 -- had another poor outing in 2023. With just a few weeks left to go, the struggling telecom and internet-infrastructure stock is down another 72% this year, continuing a long-standing downtrend for the better part of a decade now.
And... | Issues with the business model (still) being ironed out Decades after the internet began to be widely commercialized, the worldwide web is still very much a hotbed of secular growth for investors. "Cheap for a reason" has been the unshakable story Lumen's new management team went shopping and bought shares after the Q3... | As of the end of September 2023, Lumen had just $311 million in cash and short-term investments, and $1.9 billion in assets held for sale, which include the $1.5 billion net-of-tax sale of its EMEA (Europe, Middle East, and Africa) business, which closed on Nov. 1. However, unable to capitalize on secular growth trends... | The strategy involves solidifying the core business (which isn't going so well since revenue fell 17% year over year in 2023's third quarter), driving commercial excellence (better sales execution, again not going so well as of late), and innovating for growth (new products to sell customers, especially to businesses).... | That said, the market clearly thinks Lumen is still deep in the woods even with yet another business sale to pay down debt. 10 stocks we like better than Lumen Technologies When our analyst team has a stock tip, it can pay to listen. The Motley Fool has positions in and recommends Microsoft. |
45756.0 | 2023-12-10 00:00:00 UTC | The "Boring" Business Beating Amazon by 3X | ACGLO | https://www.nasdaq.com/articles/the-boring-business-beating-amazon-by-3x | nan | nan | If you've never seen a steelmaking operation in person, it's a loud, hot, bright, exciting process. That excitement might not translate into owning a steel stock, but maybe it should. Take the stock of North America's largest steelmaker, Nucor (NYSE: NUE), for example.
The steelmaking process alone isn't the only thing... | NUE Total Return Price data by YCharts That performance didn't come because Nucor is some small start-up breaking out or because it pioneered a breakthrough technology in recent years. So while investors should expect cyclicality in Nucor's stock price, it can grow over the longer term as it has more assets contributin... | So while investors should expect cyclicality in Nucor's stock price, it can grow over the longer term as it has more assets contributing to its bottom line. While the steel business takes a large amount of capital even just to maintain and upgrade existing assets, Nucor has been investing a large amount of money for gr... | Eye-popping results The return from Nucor stock alone has trounced Amazon over the last five years, and the total return including dividends has tripled that of Amazon. Sometimes in investing boring is good, and Nucor is one boring stock that could continue to bring in surprising returns going forward. See the 10 stock... | Eye-popping results The return from Nucor stock alone has trounced Amazon over the last five years, and the total return including dividends has tripled that of Amazon. Since 2017, the company has poured nearly $14 billion into growth investments and acquisitions. An enviable financial position Even with all the capita... |
45757.0 | 2023-12-10 00:00:00 UTC | History Says the Nasdaq Will Surge in 2024: 1 Magnificent Artificial Intelligence (AI) Growth Stock to Buy Before It Does | ACGLO | https://www.nasdaq.com/articles/history-says-the-nasdaq-will-surge-in-2024%3A-1-magnificent-artificial-intelligence-ai | nan | nan | The troubles that Wall Street endured in 2022 are largely in the rearview mirror, and investors are looking to the future. After losing more than 35% of its value last year, the Nasdaq Composite has come roaring back, gaining 36% so far this year (as of this writing).
History shows there's likely more to come. Going ba... | Microsoft arguably helped start the current AI gold rush with a $13 billion investment in ChatGPT parent OpenAI. Microsoft was also quick to integrate AI into many of the company's most widely used popular products and services, forming the foundation for the next phase of its growth. Evercore ISI analyst Kirk Materne ... | Azure is gaining on AWS It's widely acknowledged that cloud infrastructure providers are uniquely positioned to provide AI services to the masses. Azure's Cloud revenue grew 29% year over year, outpacing both Alphabet's Google Cloud and AWS, which grew 22% and 12%, respectively. After all, the newsletter they have run ... | Microsoft's "fastest-growing" business While AI has been around for decades, it's the recent advances in generative AI that have investors most excited. Microsoft was also quick to integrate AI into many of the company's most widely used popular products and services, forming the foundation for the next phase of its gr... | Microsoft's "fastest-growing" business While AI has been around for decades, it's the recent advances in generative AI that have investors most excited. Microsoft was also quick to integrate AI into many of the company's most widely used popular products and services, forming the foundation for the next phase of its gr... |
45758.0 | 2023-12-10 00:00:00 UTC | 49.5% of Warren Buffett's $361 Billion Portfolio Is Invested in 3 Artificial Intelligence (AI) Stocks. And That Number's Getting Bigger. | ACGLO | https://www.nasdaq.com/articles/49.5-of-warren-buffetts-%24361-billion-portfolio-is-invested-in-3-artificial-intelligence-ai | nan | nan | Warren Buffett has never been one to follow trends in technology. Nonetheless, his investment portfolio for Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) has become heavily weighted toward one of the biggest technology trends of the last decade: artificial intelligence (AI).
Nearly half of Berkshire's $361 billion por... | Buffett previously lamented his inability to get a handle on the power of the Amazon business model and the value of the company as the big reason stopping him from buying the stock earlier. From product recommendations to supply chain management to its logistics routing, AI is essential to improving Amazon's bottom li... | Apple: 48.8% of Berkshire Hathaway's portfolio Berkshire Hathaway first bought shares of Apple (NASDAQ: AAPL) in 2016 and has continued to buy shares. Amazon: 0.4% of Berkshire Hathaway's portfolio Berkshire Hathaway owns 10 million shares of Amazon (NASDAQ: AMZN) after giving its position a slight trim last quarter. S... | Apple: 48.8% of Berkshire Hathaway's portfolio Berkshire Hathaway first bought shares of Apple (NASDAQ: AAPL) in 2016 and has continued to buy shares. Apple is also starting to invest heavily in the forefront of AI development: generative AI. Amazon: 0.4% of Berkshire Hathaway's portfolio Berkshire Hathaway owns 10 mil... | Apple: 48.8% of Berkshire Hathaway's portfolio Berkshire Hathaway first bought shares of Apple (NASDAQ: AAPL) in 2016 and has continued to buy shares. There's a lot for Buffett to like about Apple. The Motley Fool has positions in and recommends Amazon, Apple, Berkshire Hathaway, and Snowflake. |
45759.0 | 2023-12-10 00:00:00 UTC | Conspiracy theorist Alex Jones reinstated on X after Musk poll | ACGLO | https://www.nasdaq.com/articles/conspiracy-theorist-alex-jones-reinstated-on-x-after-musk-poll | nan | nan | By Mrinmay Dey and Jyoti Narayan
Dec 10 (Reuters) - Social media platform X, formerly known as Twitter,on Sunday showed the account of U.S. right-wing conspiracy theorist Alex Jones to have been reinstated as a poll organized by owner Elon Musk backed his return after a ban of nearly five years.
Close to 2 million vote... | By Mrinmay Dey and Jyoti Narayan Dec 10 (Reuters) - Social media platform X, formerly known as Twitter,on Sunday showed the account of U.S. right-wing conspiracy theorist Alex Jones to have been reinstated as a poll organized by owner Elon Musk backed his return after a ban of nearly five years. The ban came weeks afte... | By Mrinmay Dey and Jyoti Narayan Dec 10 (Reuters) - Social media platform X, formerly known as Twitter,on Sunday showed the account of U.S. right-wing conspiracy theorist Alex Jones to have been reinstated as a poll organized by owner Elon Musk backed his return after a ban of nearly five years. Jones' account with use... | By Mrinmay Dey and Jyoti Narayan Dec 10 (Reuters) - Social media platform X, formerly known as Twitter,on Sunday showed the account of U.S. right-wing conspiracy theorist Alex Jones to have been reinstated as a poll organized by owner Elon Musk backed his return after a ban of nearly five years. Jones' account with use... | By Mrinmay Dey and Jyoti Narayan Dec 10 (Reuters) - Social media platform X, formerly known as Twitter,on Sunday showed the account of U.S. right-wing conspiracy theorist Alex Jones to have been reinstated as a poll organized by owner Elon Musk backed his return after a ban of nearly five years. Jones' account with use... |
45760.0 | 2023-12-10 00:00:00 UTC | Zuckerberg’s Fortune Soared With META in 2023: Can It Boost Your Wealth in 2024? | ACGLO | https://www.nasdaq.com/articles/zuckerbergs-fortune-soared-with-meta-in-2023%3A-can-it-boost-your-wealth-in-2024 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Except for Elon Musk, Meta Platforms (NASDAQ:META) CEO Mark Zuckerberg has gained the most wealth in 2023, up $72.7 billion through Dec. 7. Most is from the 162% gain in META stock. Thanks to 2023’s massive gains, Zuckerberg has returned to the Bloomberg Bi... | — and removing payment friction should lead to higher conversion for AMZN’s ads on META,’ wrote a team of Morgan Stanley analysts led by Brian Nowak. “Fitch expects the drag on credit profiles from the advertising recession, streaming platform losses and prior M&A activity to lighten during 2024,” said Senior Director ... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Except for Elon Musk, Meta Platforms (NASDAQ:META) CEO Mark Zuckerberg has gained the most wealth in 2023, up $72.7 billion through Dec. 7. ‘As such, we expect these ads to lead to faster META ad revenue growth and faster transaction growth for AMZN,’” Inve... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Except for Elon Musk, Meta Platforms (NASDAQ:META) CEO Mark Zuckerberg has gained the most wealth in 2023, up $72.7 billion through Dec. 7. How Analysts View META Stock Meta delivered three consecutive quarters with positive earnings surprises. However, Fit... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Except for Elon Musk, Meta Platforms (NASDAQ:META) CEO Mark Zuckerberg has gained the most wealth in 2023, up $72.7 billion through Dec. 7. In Q3, its earnings per share were $4.39, 21% higher than the analyst estimate. However, Fitch Ratings recently said ... |
45761.0 | 2023-12-10 00:00:00 UTC | MorphoSys : Pelabresib Improves All Four Hallmarks Of Myelofibrosis In Phase 3 Study | ACGLO | https://www.nasdaq.com/articles/morphosys-%3A-pelabresib-improves-all-four-hallmarks-of-myelofibrosis-in-phase-3-study | nan | nan | (RTTNews) - MorphoSys AG (MOR) said that results from the Phase 3 MANIFEST-2 study, which investigated an investigational BET inhibitor "pelabresib" in combination with the JAK inhibitor ruxolitinib in JAK inhibitor-nave patients with myelofibrosis, demonstrated clear benefits across the four hallmarks of myelofibrosis... | (RTTNews) - MorphoSys AG (MOR) said that results from the Phase 3 MANIFEST-2 study, which investigated an investigational BET inhibitor "pelabresib" in combination with the JAK inhibitor ruxolitinib in JAK inhibitor-nave patients with myelofibrosis, demonstrated clear benefits across the four hallmarks of myelofibrosis... | (RTTNews) - MorphoSys AG (MOR) said that results from the Phase 3 MANIFEST-2 study, which investigated an investigational BET inhibitor "pelabresib" in combination with the JAK inhibitor ruxolitinib in JAK inhibitor-nave patients with myelofibrosis, demonstrated clear benefits across the four hallmarks of myelofibrosis... | (RTTNews) - MorphoSys AG (MOR) said that results from the Phase 3 MANIFEST-2 study, which investigated an investigational BET inhibitor "pelabresib" in combination with the JAK inhibitor ruxolitinib in JAK inhibitor-nave patients with myelofibrosis, demonstrated clear benefits across the four hallmarks of myelofibrosis... | In MANIFEST-2 study, all hallmarks were improved with the pelabresib and ruxolitinib combination versus placebo plus ruxolitinib, which is the standard of care in myelofibrosis. In the MANIFEST-2 study, pelabresib and ruxolitinib demonstrated a near doubling in the proportion of patients achieving a 35% reduction in sp... |
45762.0 | 2023-12-10 00:00:00 UTC | 94% of Hershey's Profit Comes From Candy. But the Future Success of Its Business Is Riding on Something Else Entirely. | ACGLO | https://www.nasdaq.com/articles/94-of-hersheys-profit-comes-from-candy.-but-the-future-success-of-its-business-is-riding | nan | nan | Every year for over 30 years, consumers have been shown the exact same Christmas commercial. The Christmas Bells from The Hershey Company (NYSE: HSY) shows Hershey's Kisses playing a Christmas song like a handbell choir. It feels appropriate that Hershey's most famous commercial features Hershey's Kisses. After all, th... | In Harvard Business Review, Buck wrote, "We set a bold new strategy: to make Hershey a snacking powerhouse by expanding into the savory and better-for-you product categories." The company's debt is being paid back down, the cash position isn't down by a troubling amount, and management has marginally reduced its outsta... | HSY Total Long Term Debt (Quarterly) data by YCharts Through the first three quarters of 2023, net sales for Hershey's salty snacks segment are up 17.2% from the comparable period of 2022, making this its fastest growing segment. All of this said, I believe there's a stronger case for holding Hershey stock than buying ... | The Christmas Bells from The Hershey Company (NYSE: HSY) shows Hershey's Kisses playing a Christmas song like a handbell choir. HSY Total Long Term Debt (Quarterly) data by YCharts Through the first three quarters of 2023, net sales for Hershey's salty snacks segment are up 17.2% from the comparable period of 2022, mak... | Can Hershey keep it going? For example, even though Hershey has spent billions of dollars acquiring other companies, these acquisitions haven't been at the expense of shareholders. Therefore, while I wouldn't buy the shares today, I believe Hershey is a good stock to continue holding for those who already own it. |
45763.0 | 2023-12-10 00:00:00 UTC | AMD's AI Superchip Is Finally Here | ACGLO | https://www.nasdaq.com/articles/amds-ai-superchip-is-finally-here | nan | nan | The market for artificial-intelligence (AI) accelerators is dominated by Nvidia (NASDAQ: NVDA). The company reportedly sold half a million AI GPUs in the third quarter, with more than half of that total going to Microsoft and Meta Platforms. Nvidia's H100 GPUs are a hot commodity, with AI companies scrambling to secure... | AMD also touted the fact that a single MI300X accelerator can run inference on a 70 billion parameter model, which is not the case for Nvidia's products. Nvidia's CUDA platform enables developers to harness its GPUs for computation tasks, and since being first released 16 years ago, it's become the de facto industry st... | Advanced Micro Devices (NASDAQ: AMD) is looking to end Nvidia's dominance with powerful AI accelerators of its own. Before you buy stock in Advanced Micro Devices, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Advanced ... | Advanced Micro Devices (NASDAQ: AMD) is looking to end Nvidia's dominance with powerful AI accelerators of its own. Only Nvidia GPUs are supported, so switching AI chip vendors is not as simple as popping in an AMD accelerator in place of an NVIDIA accelerator. Before you buy stock in Advanced Micro Devices, consider t... | A massive leap in performance AMD is launching two AI accelerator products. Before you buy stock in Advanced Micro Devices, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Advanced Micro Devices wasn't one of them. The Mo... |
45764.0 | 2023-12-10 00:00:00 UTC | Lockheed Takes the Lead in the Race for a Nuclear Spaceship | ACGLO | https://www.nasdaq.com/articles/lockheed-takes-the-lead-in-the-race-for-a-nuclear-spaceship | nan | nan | The U.S. military likes nuclear power -- and I mean, it really likes nuclear power.
Powered by highly enriched uranium nuclear reactors, U.S. Navy submarines and aircraft carriers can operate for as long as 30 years before needing to add fuel. This frees them from the need to have oil tankers tag along on missions for ... | Powered by highly enriched uranium nuclear reactors, U.S. Navy submarines and aircraft carriers can operate for as long as 30 years before needing to add fuel. As SpaceNews reported last month, the U.S. Air Force Research Lab has hired Lockheed Martin, along with Intuitive Machines and Westinghouse Government Services,... | Lockheed goes nuclear Several months ago, if you recall, I wrote about the DRACO spaceship that NASA and DARPA -- the Defense Advanced Research Projects Agency -- were building. For $499 million, Lockheed Martin would build a small craft to test nuclear-powered spaceflight in Earth orbit, and its partner BWX Technologi... | For $499 million, Lockheed Martin would build a small craft to test nuclear-powered spaceflight in Earth orbit, and its partner BWX Technologies (NYSE: BWXT) would build a high-assay low-enriched uranium (HALEU) nuclear engine and provide the fuel to power it. As SpaceNews reported last month, the U.S. Air Force Resear... | For $499 million, Lockheed Martin would build a small craft to test nuclear-powered spaceflight in Earth orbit, and its partner BWX Technologies (NYSE: BWXT) would build a high-assay low-enriched uranium (HALEU) nuclear engine and provide the fuel to power it. Meet (George) JETSON Dubbed the Joint Emergent Technology S... |
45765.0 | 2023-12-10 00:00:00 UTC | My 2 Best -- and 2 Worst -- Stock Buys of 2023 | ACGLO | https://www.nasdaq.com/articles/my-2-best-and-2-worst-stock-buys-of-2023 | nan | nan | 2023 has been a great year for stock buyers. But not every stock has gone up. In this video, Motley Fool contributor Jason Hall takes a closer look at four stocks he bought in 2023: two that have gone up -- a lot -- since he bought them, and two that, well, didn't go up.
In addition to a look at their short-term result... | The 10 stocks that made the cut could produce monster returns in the coming years. The Motley Fool has positions in and recommends Confluent, CrowdStrike, Live Oak Bancshares, and Wolfspeed. If you choose to subscribe through their link, they will earn some extra money that supports their channel. | Stocks discussed: CrowdStrike (NASDAQ: CRWD), Live Oak Bancshares (NYSE: LOB), Confluent (NASDAQ: CFLT), and Wolfspeed (NYSE: WOLF). See the 10 stocks *Stock Advisor returns as of December 7, 2023 Jason Hall has positions in Confluent, CrowdStrike, Live Oak Bancshares, and Wolfspeed. The Motley Fool has positions in an... | In this video, Motley Fool contributor Jason Hall takes a closer look at four stocks he bought in 2023: two that have gone up -- a lot -- since he bought them, and two that, well, didn't go up. Before you buy stock in Confluent, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe... | But not every stock has gone up. Before you buy stock in Confluent, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Confluent wasn't one of them. The Motley Fool has positions in and recommends Confluent, CrowdStrike, Liv... |
45766.0 | 2023-12-10 00:00:00 UTC | This Stock Is Up 80% in 2023 -- but Could Have Another Great Year in 2024 | ACGLO | https://www.nasdaq.com/articles/this-stock-is-up-80-in-2023-but-could-have-another-great-year-in-2024 | nan | nan | Redfin (NASDAQ: RDFN) has performed exceptionally well in 2023, as management has done a great job of focusing on efficiency and maximizing the core business. But there are some reasons Redfin -- and small-cap stocks in general -- could have a great 2024, as Fool.com contributors Matt Frankel, CFP®, and Tyler Crowe dis... | Redfin (NASDAQ: RDFN) has performed exceptionally well in 2023, as management has done a great job of focusing on efficiency and maximizing the core business. But there are some reasons Redfin -- and small-cap stocks in general -- could have a great 2024, as Fool.com contributors Matt Frankel, CFP®, and Tyler Crowe dis... | Before you buy stock in Redfin, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Redfin wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 7, 2023 Matthew Frankel, CFP® has positions in Redfin. The... | But there are some reasons Redfin -- and small-cap stocks in general -- could have a great 2024, as Fool.com contributors Matt Frankel, CFP®, and Tyler Crowe discuss in this video. Before you buy stock in Redfin, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best... | But there are some reasons Redfin -- and small-cap stocks in general -- could have a great 2024, as Fool.com contributors Matt Frankel, CFP®, and Tyler Crowe discuss in this video. See the 10 stocks *Stock Advisor returns as of December 7, 2023 Matthew Frankel, CFP® has positions in Redfin. The Motley Fool has position... |
45767.0 | 2023-12-10 00:00:00 UTC | 3 Magnificent Stocks to Buy Before 2023 Is Over | ACGLO | https://www.nasdaq.com/articles/3-magnificent-stocks-to-buy-before-2023-is-over | nan | nan | Before you close the book on 2023, it's wise to look at what's available in the market and see if there's some value. Many fund managers will make large moves as soon as the calendar flips to align their portfolios with what they think will win in 2024.
As a result, some stocks that look like bargains now may not be so... | Every fund manager and advisor wants to tell their clients they're investing in the best AI companies, which is why investors should exhibit some urgency in acquiring these stocks. With the addition of AI into its product, UiPath can expand the type of information it can autofill and monitor users to pinpoint which tas... | Three that fall into this camp are Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL), UiPath (NYSE: PATH), and ASML (NASDAQ: ASML). With increasing demand for devices that can run AI models, ASML will see strong demand for its machines well into the future. At just over 10x sales (the recent spike was due to a strong response fr... | Three that fall into this camp are Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL), UiPath (NYSE: PATH), and ASML (NASDAQ: ASML). Buying this trio before 2023 begins is a smart move For ASML, it should be no surprise that the company trades at a premium valuation, due to its market dominance. See the 10 stocks *Stock Advisor r... | But what makes these companies solid buys now? That makes it a strong buy. That's right -- they think these 10 stocks are even better buys. |
45768.0 | 2023-12-10 00:00:00 UTC | 3 Unstoppable Stocks to Buy Right Now | ACGLO | https://www.nasdaq.com/articles/3-unstoppable-stocks-to-buy-right-now-0 | nan | nan | What are some unstoppable stocks to buy right now? Three Fool.com contributors think they've found three stocks that qualify -- and they're all in the healthcare sector. Here's why they picked Axsome Therapeutics (NASDAQ: AXSM), Eli Lilly (NYSE: LLY), and Vertex Pharmaceuticals (NASDAQ: VRTX).
Axsome: Modestly priced s... | Auvelity, its treatment for major depressive disorder, obtained approval last year and is now the company's top product, generating just under $38 million in sales for the period ended Sept. 30. However, with more growth on the horizon and its financials potentially getting better as Auvelity brings in more revenue, Ax... | Here's why they picked Axsome Therapeutics (NASDAQ: AXSM), Eli Lilly (NYSE: LLY), and Vertex Pharmaceuticals (NASDAQ: VRTX). Eli Lilly: This giant drugmaker keeps getting bigger Keith Speights (Eli Lilly): Eli Lilly has been a big pharmaceutical company for a long time. Vertex: The beginning of a new era Prosper Junior... | Axsome: Modestly priced stock with solid upside David Jagielski (Axsome Therapeutics): One promising growth stock that investors may be overlooking today is Axsome Therapeutics. Vertex: The beginning of a new era Prosper Junior Bakiny (Vertex Pharmaceuticals): Biotech leader Vertex Pharmaceuticals has been on a tear ov... | The biotech holds a monopoly in the market for therapies that treat the underlying causes of a rare disease called cystic fibrosis (CF). Before you buy stock in Vertex Pharmaceuticals, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy... |
45769.0 | 2023-12-10 00:00:00 UTC | The 2023 Winner of the Boston and New York City Marathons Wasn't Wearing Shoes From Nike or Adidas. She Was in Shoes From This Hot Growth Stock Company. | ACGLO | https://www.nasdaq.com/articles/the-2023-winner-of-the-boston-and-new-york-city-marathons-wasnt-wearing-shoes-from-nike-or | nan | nan | Kenyan athlete Hellen Obiri is taking the long-distance running world by storm in 2023, winning both the prestigious Boston Marathon in April and the New York City Marathon in November.
Obiri worked hard for this moment, so I don't want it to sound as though her choice of shoe was the determining factor in her victorie... | But this year, Obiri wore shoes from the more obscure brand On (NYSE: ONON), further thrusting the company into the limelight. As Warren Buffett wrote in his 1982 letter to Berkshire Hathaway shareholders, "For the investor, a too-high purchase price for the stock of an excellent company can undo the effects of a subse... | In normal years, the winners of the Boston Marathon and the New York City Marathon are wearing running shoes from well-known brands such as Nike, Adidas, Under Armour, and Skechers. The growing brand awareness and DTC sales are key for On's business. The Motley Fool has positions in and recommends Berkshire Hathaway, N... | Meet the winning shoe company On is a Swiss company specializing in running shoes. As Warren Buffett wrote in his 1982 letter to Berkshire Hathaway shareholders, "For the investor, a too-high purchase price for the stock of an excellent company can undo the effects of a subsequent decade of favorable business developme... | Should investors buy On stock? Here's why I think investors should wait for a better price for On stock. The Motley Fool recommends Crocs and recommends the following options: long January 2025 $47.50 calls on Nike. |
45770.0 | 2023-12-10 00:00:00 UTC | 4 Magnificent Stocks That I'm "Never" Selling | ACGLO | https://www.nasdaq.com/articles/4-magnificent-stocks-that-im-never-selling | nan | nan | There are a few stocks in my portfolio that I have in the "never sell" category. Now, "never" doesn't necessarily mean "never," as directional shakeups or other unforeseen events could cause me to change my stance on a business. But, as of right now, there's no way I'm selling Mastercard (NYSE: MA), Visa (NYSE: V), Cos... | Its warehouse stores are popular shopping destinations with full stalls, and the retailer boasts an incredibly loyal membership base. Right now, it's rolling out its generative AI product, Adobe Firefly, which allows users to edit images based on simple text inputs. This can also be incorporated into a marketing email ... | But, as of right now, there's no way I'm selling Mastercard (NYSE: MA), Visa (NYSE: V), Costco Wholesale (NASDAQ: COST), or Adobe (NASDAQ: ADBE). COST PE Ratio data by YCharts It trades at 43 times earnings -- a high valuation to pay for any company, let alone a retailer. The Motley Fool recommends the following option... | But, as of right now, there's no way I'm selling Mastercard (NYSE: MA), Visa (NYSE: V), Costco Wholesale (NASDAQ: COST), or Adobe (NASDAQ: ADBE). See the 10 stocks *Stock Advisor returns as of December 4, 2023 Keithen Drury has positions in Adobe, Costco Wholesale, Mastercard, and Visa. The Motley Fool recommends the f... | As a result, I don't think Costco will be a stock I will ever sell. That's right -- they think these 10 stocks are even better buys. The Motley Fool has positions in and recommends Adobe, Costco Wholesale, Mastercard, and Visa. |
45771.0 | 2023-12-10 00:00:00 UTC | Tesla Crushed the Market This Year: Is It a Stock to Own in 2024? | ACGLO | https://www.nasdaq.com/articles/tesla-crushed-the-market-this-year%3A-is-it-a-stock-to-own-in-2024 | nan | nan | Last year, I wrote that Tesla (NASDAQ: TSLA) was a stock that investors should avoid in 2023. Boy, was I wrong about that one. The electric vehicle (EV) leader saw its shares rise 94% so far this year, crushing the S&P 500, which has returned less than just 20% year to date (YTD). Despite wild antics from CEO Elon Musk... | Despite wild antics from CEO Elon Musk -- who is taking a lot of time managing his acquisition of Twitter -- and declining profit margins, investors have shown extreme optimism for Tesla in 2023. Both Ford and General Motors paired back their growth plans for EV product lines after seeing falling demand from customers ... | Tesla has a few in the pipeline, including the Cybertruck, Tesla Semi, and a premium Roadster vehicle. It is unclear when the Semi or Roadster will start hitting the production lines, but the Cybertruck is now finally bringing vehicles out to customers. The Motley Fool recommends General Motors and recommends the follo... | Declining selling prices, competition floundering A big theme for Tesla in 2023 was cutting prices for its EV product suite, most importantly the Model 3 and Model Y. For Tesla investors, it could be beneficial for these legacy companies to delay rolling out mass-market EV products, as they are still years behind Tesla... | Over the last 12 months, operating income is down 22% year over year. But if you are planning to buy shares of Tesla for the long haul, you need to understand the stock is pricing in a lot of earnings growth over the next five to 10 years. Find out why Tesla is one of the 10 best stocks to buy now Our analyst team has ... |
45772.0 | 2023-12-10 00:00:00 UTC | My Top Stock to Buy Before the End Of 2023 That Could Create Generational Wealth | ACGLO | https://www.nasdaq.com/articles/my-top-stock-to-buy-before-the-end-of-2023-that-could-create-generational-wealth | nan | nan | After passing $3 trillion in market cap on Dec. 5, Apple (NASDAQ: AAPL) stock is within 3% of its all-time high. Buying Apple decades ago produced unbelievable gains. But even more recent investors, like Warren Buffett-led Berkshire Hathaway, have seen market-crushing returns in a span of just seven years.
Once a compa... | Betting on the future Apple's performance this year shows that the market expects the company to have no problem returning to growth. It also has the cash flow to make acquisitions, accelerate its organic growth, and buy back its own stock to boost earnings per share. But it also stands the best chance at producing gen... | After passing $3 trillion in market cap on Dec. 5, Apple (NASDAQ: AAPL) stock is within 3% of its all-time high. Apple's revenue, net income, and free cash flow all declined between fiscal 2022 and 2023. Apple's services include Apple Pay, Apple TV+, Apple Podcasts, Apple Music, and more. | Apple's services include Apple Pay, Apple TV+, Apple Podcasts, Apple Music, and more. If Apple stock goes on a big run like it did this year, Apple is still there to buy its own stock. Before you buy stock in Apple, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 b... | Over the last 10 years, buybacks have been just as important to Apple's EPS growth as the operations of the business have been. If Apple stock goes on a big run like it did this year, Apple is still there to buy its own stock. Before you buy stock in Apple, consider this: The Motley Fool Stock Advisor analyst team just... |
45773.0 | 2023-12-10 00:00:00 UTC | My Top 3 Stocks for Millennials and Gen Z Investors to Buy Right Now | ACGLO | https://www.nasdaq.com/articles/my-top-3-stocks-for-millennials-and-gen-z-investors-to-buy-right-now | nan | nan | Millennials and Gen Z individuals have an investing superpower that others don't: time. Time lets compounding do the heavy lifting in creating life-changing wealth over decades.
But only some people are taking advantage. According to a research study by The Motley Fool, just 41% of Millennial and Gen Z investors use re... | The study showed that growth and dividend stocks are popular investing strategies for young investors, so here are three great companies you can buy right now that fit the bill. Berkshire is Buffett's life's work, a sprawling conglomerate that owns independent businesses, like GEICO insurance, Duracell, Dairy Queen, an... | Additionally, Berkshire has stakes in public companies like Apple, Coca-Cola, American Express, Bank of America, and more. The Motley Fool has positions in and recommends Apple, Bank of America, Berkshire Hathaway, and Tesla. The Motley Fool recommends Philip Morris International and recommends the following options: l... | The study showed that growth and dividend stocks are popular investing strategies for young investors, so here are three great companies you can buy right now that fit the bill. Berkshire Hathaway is his holding company, which contains a plethora of businesses and stock investments inside it. See the 10 stocks *Stock A... | Factor in Tesla's innovative new products like the Cybertruck, and Tesla could continue growing its vehicle business for years. That's right -- they think these 10 stocks are even better buys. The Motley Fool has positions in and recommends Apple, Bank of America, Berkshire Hathaway, and Tesla. |
45774.0 | 2023-12-10 00:00:00 UTC | Is Now the Right Time to Buy AstraZeneca Stock? | ACGLO | https://www.nasdaq.com/articles/is-now-the-right-time-to-buy-astrazeneca-stock | nan | nan | With shares of AstraZeneca (NASDAQ: AZN) returning 55% over the last three years, easily topping the market's return of 29%, it's no surprise why investors might be curious about whether there's more upside in store.
But is now the best time to buy the stock, given its upcoming catalysts and recent financial performanc... | It's making a licensing deal with a biotech called Eccogene to capture some of the highly lucrative obesity-therapies market with a program similar to Novo Nordisk's blockbuster drug Ozempic that's slated to enter phase 2 trials in 2024. As if that weren't enough, AstraZeneca is also launching a new digital-health busi... | Management is hard at work with business development deals to ensure that the pipeline remains chock-full of opportunities. See the 10 stocks *Stock Advisor returns as of December 4, 2023 Alex Carchidi has no position in any of the stocks mentioned. The Motley Fool recommends AstraZeneca Plc and Novo Nordisk. | The case for buying AstraZeneca stock now The bull thesis for investing in AstraZeneca is that it's making a lot of big bets to ensure that its future will be more profitable than its recent past (which wasn't half bad). 10 stocks we like better than AstraZeneca Plc When our analyst team has a stock tip, it can pay to ... | It has more than 120 programs in mid-to-late-stage clinical development, meaning that they could reach the market within a few years. If you're looking for big growth, this isn't it. * They just revealed what they believe are the ten best stocks for investors to buy right now... and AstraZeneca Plc wasn't one of them! |
45775.0 | 2023-12-10 00:00:00 UTC | Ford Stock: Buy, Sell, or Hold? | ACGLO | https://www.nasdaq.com/articles/ford-stock%3A-buy-sell-or-hold-0 | nan | nan | Most readers are probably familiar with Ford Motor Company (NYSE: F). It has long been a pillar of American industrial success. The business was founded more than a century ago. But the stock hasn't been a winner for shareholders. It's up just 16% in the last five years. During the same time, the S&P 500 index grew 69%... | Business updates The top news that has impacted Ford in recent times was the autoworkers' strike, which shut down production at some factories for six weeks. Weaker demand for EVs, as well as increasing costs for materials, led management to push out $12 billion it had planned to spend on EV-related investments and cap... | So, is this top Detroit automaker's stock a buy, sell, or hold for your portfolio? The case to buy and/or hold Ford stock Ford has undoubtedly been dealing with some issues, but I can see why some investors might be inclined to buy the stock right now. After all, the newsletter they have run for over a decade, Motley F... | The case to buy and/or hold Ford stock Ford has undoubtedly been dealing with some issues, but I can see why some investors might be inclined to buy the stock right now. As an investor who wants to own a stock for at least the next five years, I view Ford as a no-brainer sell because the company doesn't have an economi... | Even more noteworthy, the autoworkers' strike will end up costing Ford nearly $9 billion in additional employee costs over the roughly four years of the new contract. As an investor who wants to own a stock for at least the next five years, I view Ford as a no-brainer sell because the company doesn't have an economic m... |
45776.0 | 2023-12-10 00:00:00 UTC | AMD Takes The Fight To Nvidia With Latest AI Chip Launch. Is The Stock A Buy At $116? | ACGLO | https://www.nasdaq.com/articles/amd-takes-the-fight-to-nvidia-with-latest-ai-chip-launch.-is-the-stock-a-buy-at-%24116 | nan | nan | Advanced Micro Devices stock (NASDAQ: AMD) hosted an event to unveil its latest chips tailor-made for the booming artificial intelligence (AI) market. The newly launched chips include the Instinct MI300X – the third iteration of AMD’s Instinct line of data center GPUs – and the Instinct MI300A, a CPU-GPU hybrid chip f... | Advanced Micro Devices stock (NASDAQ: AMD) hosted an event to unveil its latest chips tailor-made for the booming artificial intelligence (AI) market. In fact, consistently beating the S&P 500 – in good times and bad – has been difficult over recent years for individual stocks; for heavyweights in the Information Techn... | While AMD says that training performance for a large language model will be similar, the improved memory capabilities should result in greater cost savings, which could be crucial given the scale at which AI models operate. However, AMD isn’t forecasting sizable sales for its new AI chips just yet, indicating that its ... | Now, AMD is an established player in the GPU space, although its chips have typically been used more for gaming and professional applications compared to Nvidia’s chips which have been the go-to chips for accelerated computing. That said, Nvidia does have an edge compared to AMD given that it has spent years developing... | The memory specs of the new AMD chip are also ahead of Nvidia’s newest chip, called the H200, which is expected to be launched during the second quarter of 2024. However, AMD isn’t forecasting sizable sales for its new AI chips just yet, indicating that its total data center GPU revenue for 2024 could come in at about ... |
45777.0 | 2023-12-10 00:00:00 UTC | AECOM Shares Approach 52-Week High - Market Mover | ACGLO | https://www.nasdaq.com/articles/aecom-shares-approach-52-week-high-market-mover-3 | nan | nan | AECOM (ACM) shares closed today at 0.9% below its 52 week high of $92.38, giving the company a market cap of $12B. The stock is currently up 8.3% year-to-date, up 9.9% over the past 12 months, and up 229.9% over the past five years. This week, the Dow Jones Industrial Average rose 0.0%, and the S&P 500 rose 0.2%.
Tradi... | AECOM (ACM) shares closed today at 0.9% below its 52 week high of $92.38, giving the company a market cap of $12B. Beta, a measure of the stock’s volatility relative to the overall market stands at 0.9. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis... | This week, the Dow Jones Industrial Average rose 0.0%, and the S&P 500 rose 0.2%. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and ... | Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same ... | This week, the Dow Jones Industrial Average rose 0.0%, and the S&P 500 rose 0.2%. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and ... |
45778.0 | 2023-12-10 00:00:00 UTC | AbbVie Just Announced 2 Big Acquisitions: Is This Dividend King a No-Brainer Buy Right Now? | ACGLO | https://www.nasdaq.com/articles/abbvie-just-announced-2-big-acquisitions%3A-is-this-dividend-king-a-no-brainer-buy-right-now | nan | nan | Change the narrative: That's been a classic strategy for businesses facing stiff challenges. And it's a strategy that AbbVie (NYSE: ABBV) appears to have pulled off successfully in recent days.
During 2023 investors have primarily focused on the company's declining revenue and profits, which stem from the loss of paten... | During 2023 investors have primarily focused on the company's declining revenue and profits, which stem from the loss of patent exclusivity for its top-selling autoimmune-disease drug Humira. The main one to watch is pivekimab sunirine, which is in a pivotal phase 2 study in treating blastic plasmacytoid dendritic cell... | On Nov. 30, AbbVie announced its plans to acquire ImmunoGen (NASDAQ: IMGN) in an all-cash transaction valued at roughly $10.1 billion. Only seven days after announcing its acquisition of ImmunoGen, AbbVie revealed plans to also acquire Cerevel Therapeutics (NASDAQ: CERE). Before you buy stock in AbbVie, consider this: ... | How acquiring ImmunoGen and Cerevel will help AbbVie Acquiring ImmunoGen should make a quicker splash for AbbVie. I don't think the ImmunoGen and Cerevel acquisitions are obvious reasons to buy AbbVie stock right now. Before you buy stock in AbbVie, consider this: The Motley Fool Stock Advisor analyst team just identif... | I don't think the ImmunoGen and Cerevel acquisitions are obvious reasons to buy AbbVie stock right now. And with a current yield of nearly 4.2%, the stock doesn't have to rise very much for investors to enjoy exceptional total returns. Before you buy stock in AbbVie, consider this: The Motley Fool Stock Advisor analyst... |
45779.0 | 2023-12-10 00:00:00 UTC | Ready to Get Paid? 3 Stocks Boosting Their Dividends in 2024 | ACGLO | https://www.nasdaq.com/articles/ready-to-get-paid-3-stocks-boosting-their-dividends-in-2024 | nan | nan | One of the only things better than getting paid a decent dividend for for taking the risks associated with investing is seeing that dividend increasing. A regularly rising dividend is a signal from a company's management that it believes that over time, it can continue to share the fruit of its labors with its investor... | All this makes for an extremely profitable business that generates towering piles of cash, even with cigarette consumption at an all-time low in Altria's home market of the United States. The company is currently dealing with some serious issues at its Pratt & Whitney aircraft engines unit that will likely cost billion... | At recent prices, RTX shares trade for 26 times trailing cash flow, and probably a higher multiple for next year's free cash. In its 2023 report, it expects oil and natural gas demand to remain fairly steady through at least 2050. See the 10 stocks *Stock Advisor returns as of December 4, 2023 Chuck Saletta has positio... | Image source: Getty Images This payout's not going up in smoke Eric Volkman (Altria Group): There are no sure bets on the stock market for income investors, but the smart money is always on cigarette maker Altria. A fairly boring business that has already promised a higher payout for 2024 Chuck Saletta (Enbridge): Cana... | It's especially noteworthy for Enbridge because of the type of business it's in: energy pipelines. Get started now As awesome as it can be to own companies that boost their dividends over time, only people who buy and hold their shares for years on end will see the long-term financial benefits that can accrue from this... |
45780.0 | 2023-12-10 00:00:00 UTC | Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? | ACGLO | https://www.nasdaq.com/articles/should-you-buy-the-3-highest-paying-dividend-stocks-in-the-dow-jones-8 | nan | nan | Some investors view high dividend yields in a negative light. They think any stock with an especially high yield is one to avoid.
Others, though, embrace such stocks. There are even investing strategies focused on buying blue-chip stocks in the Dow Jones Industrial Average with the highest yields. The idea is that thes... | In addition to this high yield, the company claims the best track record in the telecommunications industry with 17 consecutive years of dividend increases. The company operates in a highly competitive industry but is taking smart steps to attract new customers and retain existing ones. The company's Q3 update provided... | Walgreens Boots Alliance Walgreens Boots Alliance (NASDAQ: WBA) easily ranks at the top of our list. In addition to this high yield, the company claims the best track record in the telecommunications industry with 17 consecutive years of dividend increases. Before you buy stock in 3M, consider this: The Motley Fool Sto... | Verizon Communications Verizon Communications (NYSE: VZ) comes in second place among Dow stocks with its dividend yield of nearly 6.9%. Before you buy stock in 3M, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and 3M wasn't... | Some investors view high dividend yields in a negative light. I think this Dow stock is a good pick for income investors. Before you buy stock in 3M, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and 3M wasn't one of them. |
45781.0 | 2023-12-10 00:00:00 UTC | Proceed With Caution When Considering These 5 Ultra-Popular Stocks | ACGLO | https://www.nasdaq.com/articles/proceed-with-caution-when-considering-these-5-ultra-popular-stocks-10 | nan | nan | Many investors reaped big profits by chasing high-flying stocks during the meme stock rally in 2021. Unfortunately, investors who got greedy also ended up holding the bag as rising interest rates popped their bubbly valuations over the past two years.
As interest rates stabilize, we're seeing the bulls rush back toward... | On the bright side, Palantir turned profitable on a generally accepted accounting principles (GAAP) basis over the past four quarters as it reined in its stock-based compensation. Snowflake also remains deeply unprofitable on a GAAP basis, and its rapid growth is driving cloud giants like Amazon and Microsoft to upgrad... | As interest rates stabilize, we're seeing the bulls rush back toward some of those stocks -- including C3.ai (NYSE: AI), Palantir Technologies (NYSE: PLTR), Snowflake (NYSE: SNOW), Symbotic (NASDAQ: SYM), and Coinbase (NASDAQ: COIN). The AI company expects its revenue growth to accelerate again this year as the macro e... | As interest rates stabilize, we're seeing the bulls rush back toward some of those stocks -- including C3.ai (NYSE: AI), Palantir Technologies (NYSE: PLTR), Snowflake (NYSE: SNOW), Symbotic (NASDAQ: SYM), and Coinbase (NASDAQ: COIN). The AI company expects its revenue growth to accelerate again this year as the macro e... | Coinbase Lastly, Coinbase's stock has more than tripled over the past 12 months as the cryptocurrency market warmed up again. But before buying Coinbase, investors should recognize two risks: the crypto market's recovery could be disrupted by tighter regulations, and its stock still isn't cheap at 10 times next year's ... |
45782.0 | 2023-12-10 00:00:00 UTC | Vertex Pharmaceuticals Just Proved Something Big to Investors. Time to Buy? | ACGLO | https://www.nasdaq.com/articles/vertex-pharmaceuticals-just-proved-something-big-to-investors.-time-to-buy | nan | nan | Vertex Pharmaceuticals (NASDAQ: VRTX) has built a billion-dollar cystic fibrosis (CF) treatment empire, but investors have been looking for something more. They've hoped to see the company broaden its work into other areas to add an extra lift to long-term growth.
When Vertex announced the failure of two candidates to ... | On top of all this, Vertex aims to serve a smaller portion of CF patients who can't be helped by the company's current drugs. Considering all this, it's clear Casgevy's revenue won't reach the levels of Vertex's CF portfolio -- or even star product Trikafta. That looks like a bargain price to pay for a company with a s... | Vertex's blockbuster revenue First, it's important to note that Vertex's dominance in CF -- and the blockbuster revenue thanks to CF drugs -- is far from over. Before you buy stock in Vertex Pharmaceuticals, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stoc... | When Vertex announced the failure of two candidates to treat alpha-1 antitrypsin deficiency (AATD), an inherited disorder affecting the lungs and liver, back in 2020 and 2021, investors took the news particularly hard -- seeing this as a sign Vertex was struggling to expand beyond CF. Vertex's blockbuster revenue First... | Last year, CF drugs generated $8.9 billion in revenue for Vertex, with Trikafta bringing in 87% of that. The length of treatment and the question of reimbursement mean revenue growth for Vertex and CRISPR Therapeutics will take some time. Before you buy stock in Vertex Pharmaceuticals, consider this: The Motley Fool St... |
45783.0 | 2023-12-10 00:00:00 UTC | This Dividend Stock Has Doubled Since 2018. Here's Why It's Still a Buy. | ACGLO | https://www.nasdaq.com/articles/this-dividend-stock-has-doubled-since-2018.-heres-why-its-still-a-buy. | nan | nan | EQT Corp. (NYSE: EQT) has quietly delivered market-smashing total returns over the last five years. The natural gas giant has doubled in value since 2018, easily outpacing the roughly 66% return for the S&P 500 (14.6% annualized versus 10.6% annualized). Add in its dividend, and its total return is even higher.
The nat... | However, most investors are completely unaware of the company's value-creating potential because natural gas just isn't a hot commodity like oil or renewable energy. The company expected the transformational merger to create significant shareholder value by turning it into a free cash flow machine. EQT believes it can ... | Becoming a free cash flow growth machine Under Toby Rice's leadership, EQT has started to become the free cash flow machine initially envisioned in the Rice Energy merger. EQT's improving free cash flow has enabled it to start returning money to shareholders. That combination of growing cash returns and balance sheet i... | Becoming a free cash flow growth machine Under Toby Rice's leadership, EQT has started to become the free cash flow machine initially envisioned in the Rice Energy merger. EQT believes it can produce $14 billion in cumulative free cash flow through 2028 at the current projected price for natural gas. Before you buy sto... | The company has produced $642 million in free cash flow through the first nine months of this year. It's on track to produce $14 billion in free cash over the next four years, most of which it will likely return to shareholders via dividends and buybacks. Before you buy stock in EQT, consider this: The Motley Fool Stoc... |
45784.0 | 2023-12-10 00:00:00 UTC | These Crypto Executives Think Bitcoin Could Be Worth $100,000 in 2024 | ACGLO | https://www.nasdaq.com/articles/these-crypto-executives-think-bitcoin-could-be-worth-%24100000-in-2024 | nan | nan | With Bitcoin (CRYPTO: BTC) currently trading near an 18-month high of $44,000, it's perhaps no surprise that a number of analysts and investors are now rushing to put out higher price targets for Bitcoin. The growing consensus is that Bitcoin could be on a trajectory to hit $100,000 next year.
As a result, top executiv... | One of the most prominent voices calling for a rapid appreciation in the price of Bitcoin is Michael Saylor, chairman (and former CEO) of MicroStrategy (NASDAQ: MSTR). In April, Standard Chartered Bank put out a $100,000 price target for Bitcoin and, in November, reiterated its bullish stance. A handful of Wall Street ... | Crypto financial services firm Matrixport recently suggested Bitcoin could be headed to $125,000 by the end of 2024. And Adam Back, CEO of Blockstream, suggested Bitcoin might hit $100,000 before the next halving, currently scheduled for April 2024. Before you buy stock in Bitcoin, consider this: The Motley Fool Stock ... | While Saylor has not put out an official price target for Bitcoin in 2024, he recently appeared on CNBC in November and said Bitcoin had the potential to 10x in value. Wall Street joins the Bitcoin party It's one thing for crypto executives to be talking up the price of Bitcoin. Before you buy stock in Bitcoin, conside... | As a result, top executives from within the crypto industry are now chiming in on Bitcoin's prospects for 2024, with many convinced Bitcoin could more than double in value within just 12 months. While Saylor has not put out an official price target for Bitcoin in 2024, he recently appeared on CNBC in November and said ... |
45785.0 | 2023-12-10 00:00:00 UTC | Are These Low-Stress, High-Yield Dividend Stocks Flying Under Your Radar? | ACGLO | https://www.nasdaq.com/articles/are-these-low-stress-high-yield-dividend-stocks-flying-under-your-radar | nan | nan | Income investors love big dividends, but what they crave most are reliable dividends. After all, what good is a juicy payout that quickly disappears? For this reason, bank stocks have long seemed suspect to many seeking passive income. From the global financial crisis to this year's wave of bank failures, these stocks ... | There are literally thousands of competitors, from nationwide giants that handle multibillion-dollar transactions to a litany of smaller regional and local players. This stability was easily verified during the 2008 financial crisis: There were no catastrophic failures like Lehman Brothers or Bear Stearns in Canada. It... | From less competition and greater pricing power to stronger balance sheets and resilient end markets, Canadian banks stocks have proven more reliable than U.S. banks stocks over the last several decades. This resilience creates reliable dividends Most U.S. bank stocks now have dividend yields ranging between 2% and 5%,... | Canadian banks like TD Bank benefit from many structural advantages, all of which have fueled higher and more reliable dividends than the average U.S. bank stock. Canadian banks aren't risk-free Keep in mind that no matter how attractive Canadian bank stocks are versus their U.S. peers, these are, after all, still bank... | From less competition and greater pricing power to stronger balance sheets and resilient end markets, Canadian banks stocks have proven more reliable than U.S. banks stocks over the last several decades. The average payout for a Canadian bank stock, meanwhile, is considerably higher. Before you buy stock in Toronto-Dom... |
45786.0 | 2023-12-10 00:00:00 UTC | 2 Stocks I'm Buying in 2024 | ACGLO | https://www.nasdaq.com/articles/2-stocks-im-buying-in-2024 | nan | nan | 2023 hasn't been good for shares of Etsy (NASDAQ: ETSY) or Enphase (NASDAQ: ENPH). But that doesn't mean the businesses aren't compelling for investors in the know. In this video, Motley Fool contributors Jason Hall and Jeff Santoro break down why these two beaten-down stocks are on their buy lists for 2024.
*Stock pri... | In this video, Motley Fool contributors Jason Hall and Jeff Santoro break down why these two beaten-down stocks are on their buy lists for 2024. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market. If you choose to subscribe through their link they will earn some... | 2023 hasn't been good for shares of Etsy (NASDAQ: ETSY) or Enphase (NASDAQ: ENPH). In this video, Motley Fool contributors Jason Hall and Jeff Santoro break down why these two beaten-down stocks are on their buy lists for 2024. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tr... | In this video, Motley Fool contributors Jason Hall and Jeff Santoro break down why these two beaten-down stocks are on their buy lists for 2024. See the 10 stocks *Stock Advisor returns as of December 4, 2023 Jason Hall has positions in Etsy. The Motley Fool has positions in and recommends Enphase Energy and Etsy. | In this video, Motley Fool contributors Jason Hall and Jeff Santoro break down why these two beaten-down stocks are on their buy lists for 2024. See the 10 stocks *Stock Advisor returns as of December 4, 2023 Jason Hall has positions in Etsy. The Motley Fool has positions in and recommends Enphase Energy and Etsy. |
45787.0 | 2023-12-10 00:00:00 UTC | Loews Corp. Shares Close in on 52-Week High - Market Mover | ACGLO | https://www.nasdaq.com/articles/loews-corp.-shares-close-in-on-52-week-high-market-mover-4 | nan | nan | Loews Corp. (L) shares closed today at 1.6% below its 52 week high of $70.88, giving the company a market cap of $15B. The stock is currently up 18.5% year-to-date, up 22.4% over the past 12 months, and up 56.2% over the past five years. This week, the Dow Jones Industrial Average rose 0.0%, and the S&P 500 rose 0.2%.
... | Loews Corp. (L) shares closed today at 1.6% below its 52 week high of $70.88, giving the company a market cap of $15B. Beta, a measure of the stock’s volatility relative to the overall market stands at 0.7. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year ... | Loews Corp. (L) shares closed today at 1.6% below its 52 week high of $70.88, giving the company a market cap of $15B. This week, the Dow Jones Industrial Average rose 0.0%, and the S&P 500 rose 0.2%. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis,... | Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same ... | This week, the Dow Jones Industrial Average rose 0.0%, and the S&P 500 rose 0.2%. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year bas... |
45788.0 | 2023-12-10 00:00:00 UTC | Looking for Next Year's Winners? These Underdog Growth Stocks Are Great Buys for 2024 and Beyond | ACGLO | https://www.nasdaq.com/articles/looking-for-next-years-winners-these-underdog-growth-stocks-are-great-buys-for-2024-and | nan | nan | Market volatility can make investors feel very uneasy about their financial future. However, wild swings in share prices give long-term investors the opportunity to score bargains before Wall Street realizes its mistake. The key is to ignore the stock market and focus on the key advantages of the underlying business.
T... | The company has seen growth slow over the last year amid macroeconomic issues, like inflation hurting consumer spending, but the stock's low valuation is too cheap to pass up. Investors are concerned about the outlook for eating out if the economy falls into a recession, not to mention the potential for competition to ... | Toast (NYSE: TOST), SentinelOne (NYSE: S), and Chewy (NYSE: CHWY) have fallen well off their highs, but these companies have continued to grow in a challenging economy, and more growth could change the market's tune in a new year. Toast Toast is a leading software platform that makes running a restaurant a lot easier. ... | Toast (NYSE: TOST), SentinelOne (NYSE: S), and Chewy (NYSE: CHWY) have fallen well off their highs, but these companies have continued to grow in a challenging economy, and more growth could change the market's tune in a new year. The latest business update for the fiscal third quarter showed revenue increasing by 8% y... | Investors should consider buying shares now because the stock may not be this cheap for long. SentinelOne said revenue grew 42% year over year in the last quarter. Chewy Chewy is another growing business that the market is significantly underestimating right now. |
45789.0 | 2023-12-10 00:00:00 UTC | 2 Artificial Intelligence (AI) Growth Stocks Up 119% and 127% This Year to Buy Now, According to Wall Street | ACGLO | https://www.nasdaq.com/articles/2-artificial-intelligence-ai-growth-stocks-up-119-and-127-this-year-to-buy-now-according | nan | nan | Excitement about artificial intelligence (AI) and its potential to boost labor productivity has sent many stocks higher this year. Shares of CrowdStrike Holdings (NASDAQ: CRWD) and Elastic (NYSE: ESTC) have more than doubled, climbing 127% and 119%, respectively.
Even so, both stocks bear a consensus rating of buy amon... | CEO George Kurtz said as much on the most recent earnings call: "Our AI trained on cybersecurity's richest dataset drives the industry's most comprehensive protection and automation." Management attributed some of the second-quarter momentum to success with generative AI tools like Elasticsearch Relevance Engine, a pro... | CrowdStrike Holdings: 127% year-to-date return CrowdStrike sells cybersecurity software. Its Falcon platform leans on artificial intelligence (AI) to protect data, identities, and workloads across devices in public clouds and private data centers. Developers can use the Elastic stack to build custom software, but the c... | In other words, Elastic should be able to engage customers with its enterprise search product, then cross-sell those customers with its security and observability products. Going forward, Elastic is well positioned to capitalize on growing demand for AI given that its platform stores and indexes data, and CEO Ash Kulka... | Its Falcon platform leans on artificial intelligence (AI) to protect data, identities, and workloads across devices in public clouds and private data centers. In other words, Elastic should be able to engage customers with its enterprise search product, then cross-sell those customers with its security and observabilit... |
45790.0 | 2023-12-10 00:00:00 UTC | This Will Be a Trillion-Dollar Industry by 2030: 4 Stocks I Own to Profit | ACGLO | https://www.nasdaq.com/articles/this-will-be-a-trillion-dollar-industry-by-2030%3A-4-stocks-i-own-to-profit | nan | nan | Artificial intelligence (AI) has powered Nvidia (NASDAQ: NVDA) to massive gains in 2024, and that's helped lift Taiwan Semiconductor (NYSE: TSM) shares as well. But those aren't the only semiconductor stocks set to win from the huge growth in the industry. In this video, Motley Fool contributor Jason Hall breaks down w... | Artificial intelligence (AI) has powered Nvidia (NASDAQ: NVDA) to massive gains in 2024, and that's helped lift Taiwan Semiconductor (NYSE: TSM) shares as well. In this video, Motley Fool contributor Jason Hall breaks down why he owns these and two others -- Texas Instruments (NASDAQ: TXN) and Wolfspeed (NYSE: WOLF). T... | Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Nvidia wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 7, 2023 Jason Hall has positions in Nvidia, Taiwan Semicon... | In this video, Motley Fool contributor Jason Hall breaks down why he owns these and two others -- Texas Instruments (NASDAQ: TXN) and Wolfspeed (NYSE: WOLF). Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors t... | In this video, Motley Fool contributor Jason Hall breaks down why he owns these and two others -- Texas Instruments (NASDAQ: TXN) and Wolfspeed (NYSE: WOLF). Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors t... |
45791.0 | 2023-12-10 00:00:00 UTC | A Bull Market Is Coming: 3 Top Stocks to Buy Before the End of the Year | ACGLO | https://www.nasdaq.com/articles/a-bull-market-is-coming%3A-3-top-stocks-to-buy-before-the-end-of-the-year | nan | nan | Last year, the three major indexes slipped into bear territory, and ever since, the question on everyone's mind has been this: When will the next bull market start? That's impossible to answer, even in a rising market such as the one we've known this year. To officially declare a bull market from this point, indexes mu... | That's because Shopify helps many of your favorite e-commerce companies operate their online stores -- providing a variety of services from creating the website to tracking sales and managing inventory. Revenue and gross profit advanced in the double digits, and the company was free cash flow positive for the fourth st... | Apple Apple (NASDAQ: AAPL) has a growth track record that speaks for itself. In the most recent quarter, services revenue reached a record high -- and this momentum is likely to continue thanks to more than 1 billion paid subscriptions. But, clearly, in a strong market environment, Apple's earnings and shares can truly... | So, as you get your portfolio ready for the new investing year, here are three top stocks to buy -- to position yourself for a potential bull market win. For example, Etsy sellers run their own shops and take care of stocking and shipping their wares -- so Etsy doesn't have to invest in storage and transport. But, clea... | For example, Etsy sellers run their own shops and take care of stocking and shipping their wares -- so Etsy doesn't have to invest in storage and transport. And that's services. But, clearly, in a strong market environment, Apple's earnings and shares can truly thrive, making it a top bull market buy. |
45792.0 | 2023-12-10 00:00:00 UTC | Australia's Sigma Healthcare signs $5.8 bln merger deal with Chemist Warehouse | ACGLO | https://www.nasdaq.com/articles/australias-sigma-healthcare-signs-%245.8-bln-merger-deal-with-chemist-warehouse | nan | nan | By Scott Murdoch and Echha Jain
Dec 11 (Reuters) - Australia's Sigma Healthcare SIG.AX on Monday said it would merge with privately owned pharmacy giant Chemist Warehouse Group to create a A$8.8 billion ($5.79 billion) entity.
Chemist Warehouse will own 85.8% of the merged company that will supply 1,000 Sigma-aligned p... | It has long been touted as a potential initial public offering (IPO) candidate but the Sigma deal gives it a backdoor way to being listed on the Australian Securities Exchange (ASX) at a time when global capital markets remain in the doldrums. Sigma said it had also signed a A$1 billion loan with ANZ Group ANZ.AX and N... | By Scott Murdoch and Echha Jain Dec 11 (Reuters) - Australia's Sigma Healthcare SIG.AX on Monday said it would merge with privately owned pharmacy giant Chemist Warehouse Group to create a A$8.8 billion ($5.79 billion) entity. The capital raising is underwritten by Goldman Sachs GS.N and partly underwritten by Sigma ma... | By Scott Murdoch and Echha Jain Dec 11 (Reuters) - Australia's Sigma Healthcare SIG.AX on Monday said it would merge with privately owned pharmacy giant Chemist Warehouse Group to create a A$8.8 billion ($5.79 billion) entity. The proposed merger has Sigma acquiring Chemist Warehouse in exchange for a stake in the comp... | By Scott Murdoch and Echha Jain Dec 11 (Reuters) - Australia's Sigma Healthcare SIG.AX on Monday said it would merge with privately owned pharmacy giant Chemist Warehouse Group to create a A$8.8 billion ($5.79 billion) entity. Chemist Warehouse will own 85.8% of the merged company that will supply 1,000 Sigma-aligned p... |
45793.0 | 2023-12-10 00:00:00 UTC | My 2 Best Stocks of 2023 (Not Named Nvidia) | ACGLO | https://www.nasdaq.com/articles/my-2-best-stocks-of-2023-not-named-nvidia | nan | nan | As it has been for many investors, Nvidia (NASDAQ: NVDA) has been Motley Fool contributors Jason Hall's and Jeff Santoro's best-performing stock so far in 2023. However, they've both had two other big winners: Dream Finders Homes (NYSE: DFH) and Upstart (NASDAQ: UPST). In this video, they discuss all three, and share w... | As it has been for many investors, Nvidia (NASDAQ: NVDA) has been Motley Fool contributors Jason Hall's and Jeff Santoro's best-performing stock so far in 2023. However, they've both had two other big winners: Dream Finders Homes (NYSE: DFH) and Upstart (NASDAQ: UPST). After all, the newsletter they have run for over a... | As it has been for many investors, Nvidia (NASDAQ: NVDA) has been Motley Fool contributors Jason Hall's and Jeff Santoro's best-performing stock so far in 2023. See the 10 stocks *Stock Advisor returns as of December 4, 2023 Jason Hall has positions in Dream Finders Homes, Nvidia, and Upstart. Jeff Santoro has position... | As it has been for many investors, Nvidia (NASDAQ: NVDA) has been Motley Fool contributors Jason Hall's and Jeff Santoro's best-performing stock so far in 2023. See the 10 stocks *Stock Advisor returns as of December 4, 2023 Jason Hall has positions in Dream Finders Homes, Nvidia, and Upstart. The Motley Fool has posit... | That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of December 4, 2023 Jason Hall has positions in Dream Finders Homes, Nvidia, and Upstart. The Motley Fool has positions in and recommends Dream Finders Homes, Nvidia, and Upstart. |
45794.0 | 2023-12-10 00:00:00 UTC | TipRanks’ ‘Perfect 10’ Picks: 2 Top-Scoring Stocks for 2024 | ACGLO | https://www.nasdaq.com/articles/tipranks-perfect-10-picks%3A-2-top-scoring-stocks-for-2024 | nan | nan | The bulls are coming out in force, and predicting solid gains for the stock market in 2024. In recent forecasts, 5 out of 8 major investment banks are predicting that the S&P 500 will hit 5,000 or better. The most bullish of these, from Tom Lee, head of research at Fundstrat, says that the index will reach as high as 5... | The combined final financial release for FQ3 prior to the split showed that VYX had $2 billion in quarterly revenue, for a 1.5% year-over-year increase, while at the bottom-line, non-GAAP EPS came to 95 cents. We are also confident in VYX's ability to reach its LT (2027) growth and profitability targets given the compa... | (To watch Tandon’s track record, click here) This stock has earned a unanimous Strong Buy consensus rating from the Street’s analyst consensus, based on 5 positive reviews set in recent weeks. Primo offers several plans for its water customers, including Water Direct, Water Exchange, and Water Refill. (To watch Zamparo... | Don’t miss BMO Optimistic About Fintech Stocks in 2024; Here Are 3 Top Picks to Keep an Eye On Mobileye, Goodyear Among Top Picks as Deutsche Bank Assesses Auto Stocks Bank of America Says the S&P 500 Will Hit a New Record High in 2024 — Here Are 2 Stocks to Play That Bullish Sentiment NCR Voyix (VYX) You may not know ... | (See VYX stock forecast) Primo Water Corporation (PRMW) Next up on our list of ‘Perfect 10’ stocks is Primo Water, a company that supplies multi-gallon bottles of drinking water to its customers. That provides a solid foundation for this year’s business, which is on track to exceed last year’s revenue. The quarterly re... |
45795.0 | 2023-12-10 00:00:00 UTC | Validea's Top Health Care Stocks Based On Peter Lynch - 12/10/2023 | ACGLO | https://www.nasdaq.com/articles/valideas-top-health-care-stocks-based-on-peter-lynch-12-10-2023 | nan | nan | The following are the top rated Health Care stocks according to Validea's P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relative to earnings growth that also possess strong balance sheets.
DANAHER CORPORATION (DHR) is a large-cap g... | The Company's Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables and services that are used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. Its Diagnostics segment offers clini... | Detailed Analysis of DANAHER CORPORATION DHR Guru Analysis DHR Fundamental Analysis ABBOTT LABORATORIES (ABT) is a large-cap growth stock in the Medical Equipment & Supplies industry. Detailed Analysis of ABBOTT LABORATORIES ABT Guru Analysis ABT Fundamental Analysis ASTRAZENECA PLC (ADR) (AZN) is a large-cap growth st... | Detailed Analysis of ASTRAZENECA PLC (ADR) AZN Guru Analysis AZN Fundamental Analysis HCA HEALTHCARE INC (HCA) is a large-cap value stock in the Healthcare Facilities industry. Detailed Analysis of HCA HEALTHCARE INC HCA Guru Analysis HCA Fundamental Analysis STAAR SURGICAL CO (STAA) is a small-cap growth stock in the ... | Company Description: Danaher Corporation designs, manufactures and markets professional, medical, industrial, and commercial products and services. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its manufacturing facility in Brugg, Switzerland, ... |
45796.0 | 2023-12-10 00:00:00 UTC | Want $400 of Passive Income? Invest $16,000 in These 2 Dividend Giants | ACGLO | https://www.nasdaq.com/articles/want-%24400-of-passive-income-invest-%2416000-in-these-2-dividend-giants | nan | nan | One great reason to love dividend stocks is that they offer purely passive income. Simply adding a few of these investments to your portfolio lets you to benefit from regular quarterly payments that also tend to rise with each passing year.
The hard part is picking the right stocks. You want a good balance between grow... | Simply adding a few of these investments to your portfolio lets you to benefit from regular quarterly payments that also tend to rise with each passing year. Ideally, the dividend stocks you own will deliver both steadily growing income and a rising share price. Coke produced $8 billion of free cash flow over the last ... | Ideally, the dividend stocks you own will deliver both steadily growing income and a rising share price. Coca-Cola: Growing strong Coca-Cola stock is a rare case of a strong, growing business that's priced at a discount. McDonald's stock pays a yield today of 2.3%, or just a bit less than Coke's roughly 3%. | Ideally, the dividend stocks you own will deliver both steadily growing income and a rising share price. 10 stocks we like better than McDonald's When our analyst team has a stock tip, it can pay to listen. See the 10 stocks *Stock Advisor returns as of December 4, 2023 Demitri Kalogeropoulos has positions in McDonald'... | Ideally, the dividend stocks you own will deliver both steadily growing income and a rising share price. And yet the dividend stock has missed out on the 2023 market rally. McDonald's stock pays a yield today of 2.3%, or just a bit less than Coke's roughly 3%. |
45797.0 | 2023-12-10 00:00:00 UTC | U.S. Money Supply Is Shrinking the Most Since the Great Depression. Does It Spell Doom for the Stock Market in 2024? | ACGLO | https://www.nasdaq.com/articles/u.s.-money-supply-is-shrinking-the-most-since-the-great-depression.-does-it-spell-doom-for | nan | nan | Predictions about how stocks will perform in the new year are already beginning to circulate. Some think the prospects should be good since the S&P 500 typically rises during U.S. presidential election years. Others foresee a mild recession on the way, which would likely cause stocks to fall.
But perhaps the most intri... | M1 is the total amount of money held by the public in cash, coins, and traveler's checks and in banks, regular savings accounts, and credit unions. Goldman Sachs economist Manual Abecasis wrote in a report earlier this year that measures such as M2 money supply haven't been reliable in forecasting what the economy will... | The current U.S. money supply shrinkage reflects the steepest decline since the Great Depression of the 1930s. It's understandable why some think that the current money supply shrinkage portends doom and gloom for the stock market in 2024. This time it's different So does the shrinking U.S. money supply spell doom for ... | Plunging money supply Money supply is simply the total amount of money in circulation. It's understandable why some think that the current money supply shrinkage portends doom and gloom for the stock market in 2024. This time it's different So does the shrinking U.S. money supply spell doom for the stock market in 2024... | Plunging money supply Money supply is simply the total amount of money in circulation. This time it's different So does the shrinking U.S. money supply spell doom for the stock market in 2024? On the other hand, I won't be surprised if the market rises with continued economic growth, relatively mild unemployment, moder... |
45798.0 | 2023-12-10 00:00:00 UTC | DraftKings Stock Rocketed 215% Higher This Year. Will the Party Continue in 2024? | ACGLO | https://www.nasdaq.com/articles/draftkings-stock-rocketed-215-higher-this-year.-will-the-party-continue-in-2024 | nan | nan | A starting shot signaled the beginning of a long race on May 14, 2018. This was the day the U.S. Supreme Court ended the federal ban on sports gambling, allowing states to decide for themselves whether to make sports gambling legal for their residents. Five years later, the market has exploded in the U.S. Over 20 state... | DraftKings recently passed competitor FanDuel to take the market share lead for gross gaming revenue in the United States. At the end of Q3, the company had over $1 billion in cash on its balance sheet, giving it plenty of firepower to continue offering attractive promos to new bettors. Management is guiding for adjust... | Five years later, the market has exploded in the U.S. Over 20 states have legalized online sports betting with tens of billions of dollars spent yearly by gamblers betting on football, basketball, and more through these online portals. One popular stock in this sector is DraftKings (NASDAQ: DKNG), a leading online spor... | Aggressive growth, increasing market share Companies like DraftKings have spent aggressively to attract people to their online betting portals. The valuation isn't crazy if you believe long-term guidance From just its existing states, DraftKings believes it can grow its revenue at a 14% compound annual growth rate (CAG... | Aggressive growth, increasing market share Companies like DraftKings have spent aggressively to attract people to their online betting portals. Last quarter, revenue was still growing quickly, up 57% year over year to $790 million. If these margin improvements continue, the company will be generating a profit within a ... |
45799.0 | 2023-12-10 00:00:00 UTC | 1 Stock Down 80% That Wall Street Expects to Rise 23% in 2024 | ACGLO | https://www.nasdaq.com/articles/1-stock-down-80-that-wall-street-expects-to-rise-23-in-2024 | nan | nan | The S&P 500 continues its rally as we get closer to the end of the year, and as of this writing it's up 19% in 2023. Tech stocks have also been making a comeback this year after getting beaten down in 2022, and the Nasdaq-100 tech index is up 52% so far this year.
But not all stocks are having an up year. Bill Holdings... | Macro headwinds are slowing down this small-business management superstar Bill sells financial software packages to smaller businesses. Bill makes it easier for these smaller businesses to run efficiently, and it counts nearly 500,000 paying subscribers as well as almost 6 million network members that can send and rece... | Fiscal 2023 revenue increased 65% year over year, but revenue increased only 33% in the FY 2024 fiscal first quarter (ended Sept. 30). It has a large addressable market of 34 million U.S. small businesses and 70 million global small businesses with almost $500 billion in software spend. Before you buy stock in Bill, co... | Fiscal 2023 revenue increased 65% year over year, but revenue increased only 33% in the FY 2024 fiscal first quarter (ended Sept. 30). Before you buy stock in Bill, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Bill wasn’... | But not all stocks are having an up year. Bill is using this time to become more efficient and position itself to become profitable when revenue growth speeds up again. Before you buy stock in Bill, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for in... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.